Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3006257	s-achr-ab	— (—)	1927	2021	100.00%	Distribution not available
3006257	s-achr-ab	nmol/l (nmol/l)	487	540	5.74%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other symptoms and signs involving the nervous and musculoskeletal systems

602

738

8.36

307.65

1.1

2.67

7.81

nmol/l

1.36

112

153

Symptoms and signs involving the nervous and musculoskeletal systems

825

1032

8.18

307.65

1.1

2.61

7.33

nmol/l

1.63

151

206

Ptosis of eyelid

314

177

18.98

307.65

1.1

4.77

14.76

nmol/l

0.54

Myasthenia gravis

246

112.74

307.65

1.3

1.1

11.98

0.10

nmol/l

—

160

Visual disturbances and blindness

780

902

8.87

307.65

1.1

3.64

6.96

nmol/l

0.79

174

172

Diseases of the myoneural junction and muscle

376

201

20.08

307.65

1.2

1.1

12.67

0.11

nmol/l

6.62

177

Visual disturbances

772

839

9.46

307.65

1.1

3.64

6.53

nmol/l

0.64

174

159

Diplopia

523

197

29.11

307.65

1.1

4.39

14.97

nmol/l

0.61

118

Strabismus

403

520

7.94

291.48

1.1

2.54

9.49

nmol/l

1.31

106

Disorders of ocular muscles, binocular movement, accommodation and refraction

533

975

5.51

272.02

1.1

2.29

7.73

nmol/l

1.94

104

197

Other disorders of eyelid

440

781

5.45

218.93

1.1

5.25

6.55

nmol/l

0.20

106

142

Disorders of eyelid, lacrimal system and orbit

696

1387

3.85

210.61

1.1

5.66

5.12

nmol/l

0.11

147

248

Neurological diseases

547

516

5.36

204.18

1.1

8.28

0.24

nmol/l

1.85

111

Malaise and fatigue

458

746

5.00

195.47

1.1

1.42

8.86

nmol/l

2.51

152

Paralytic strabismus

174

124

14.88

192.39

1.1

3.38

5.95

nmol/l

0.55

Dysphagia

291

443

6.70

181.78

1.1

5.70

8.30

nmol/l

0.32

105

Subjective visual disturbances

281

432

6.64

173.90

1.1

1.89

10.47

nmol/l

1.18

Headache

512

1025

4.03

167.75

1.1

1.43

8.06

nmol/l

2.46

195

Abnormalities of gait and mobility

186

182

10.57

167.71

1.1

0.86

10.20

nmol/l

2.29

Other strabismus

266

418

6.48

160.44

1.1

1.84

10.49

nmol/l

1.26

Diseases of the eye and adnexa

490

584

4.23

142.67

1.1

3.07

4.43

nmol/l

0.41

104

Other soft tissue disorders, not elsewhere classified

633

1199

3.12

129.15

1.1

3.35

6.64

nmol/l

0.96

103

251

Neurological diseases, wide definition

207

10.69

126.59

1.1

5.83

0.11

nmol/l

1.50

General symptoms and signs

674

1117

3.04

125.18

1.1

2.28

7.89

nmol/l

2.20

123

216

Medical observation and evaluation for suspected diseases and conditions

431

551

4.03

119.58

1.1

4.10

9.31

nmol/l

1.00

134

Migraine

368

765

3.94

117.80

1.1

1.37

6.31

nmol/l

1.32

154

Myalgia

231

439

5.34

114.81

1.1

0.40

9.66

nmol/l

1.88

Other headache syndromes

317

779

4.11

114.48

1.1

4.60

6.83

nmol/l

0.31

162

Disturbances of skin sensation

271

611

4.50

109.98

1.1

1.32

8.81

nmol/l

1.69

117

Episodal and paroxysmal disorders

651

1169

2.85

109.29

1.1

4.60

6.10

nmol/l

0.31

126

236

Pain in joint

379

647

3.76

105.30

1.1

2.02

9.08

nmol/l

1.95

145

Speech disturbances, not elsewhere classified

137

168

8.43

104.12

1.1

10.75

7.94

nmol/l

0.20

Symptoms and signs involving cognition, perception, emotional state and behaviour

619

1572

2.70

103.44

1.1

1.59

6.42

nmol/l

2.79

105

318

Disorders of thyroid, IBD co-morbidities

126

12.09

102.37

1.0

1.1

7.29

0.10

nmol/l

0.72

Symptoms and signs involving speech and voice

291

738

4.00

101.06

1.1

9.15

7.26

nmol/l

0.22

143

Abnormal involuntary movements

148

212

7.13

98.10

1.1

3.27

18.12

nmol/l

1.09

Abnormalities of breathing

556

1141

2.85

97.58

1.1

3.62

5.44

nmol/l

0.44

101

222

Polyneuropathies and other disorders of the peripheral nervous system

208

425

4.98

95.31

1.1

1.69

11.41

nmol/l

1.86

Other and unspecified polyneuropathies, also in other diseases

189

363

5.30

93.03

1.1

1.81

11.51

nmol/l

1.55

Dorsalgia

585

1169

2.69

90.64

1.1

2.53

6.95

nmol/l

1.64

107

245

Dizziness and giddiness

476

1360

2.79

88.30

1.1

1.84

6.63

nmol/l

2.22

278

Pain in limb

489

1168

2.82

88.05

1.1

3.29

6.76

nmol/l

0.98

245

Concussion

231

424

4.47

87.74

1.1

3.78

0.27

nmol/l

1.22

Intracranial trauma

258

432

4.22

86.54

1.1

3.27

0.27

nmol/l

1.21

Other neurological diseases

461

1303

2.80

85.73

1.1

1.55

6.98

nmol/l

3.10

277

Systemic atrophies primarily affecting the central nervous system

11.29

85.08

1.1

0.09

5.10

nmol/l

1.36

General examination and investigation of persons without complaint and reported diagnosis

365

549

3.49

84.94

1.1

1.62

9.38

nmol/l

2.01

133

Extrapyramidal and movement disorders

284

802

3.58

84.43

1.1

5.92

7.00

nmol/l

0.10

172

Other dorsopathies, not elsewhere classified

581

1173

2.61

83.92

1.1

3.29

6.92

nmol/l

1.14

246

Examination and observation for other reasons

334

544

3.57

83.63

1.1

1.73

9.45

nmol/l

1.97

132

Low back pain

446

1144

2.82

81.91

1.1

1.96

6.98

nmol/l

2.11

244

Symptoms and signs involving the skin and subcutaneous tissue

451

1662

2.67

80.90

1.1

2.68

5.95

nmol/l

1.40

320

Autoimmune diseases excluding thyroid diseases

584

1279

2.50

79.13

1.1

8.06

1.98

nmol/l

2.07

182

178

Anxiety disorders, excluding more controls

501

1249

2.62

78.47

1.1

2.32

6.61

nmol/l

1.49

261

Autoimmune diseases excluding thyroid diseases, strict definition

560

1230

2.51

76.10

1.1

7.65

2.07

nmol/l

1.76

176

170

Other disorders of lacrimal gland

243

666

3.69

75.59

1.1

6.23

6.50

nmol/l

0.03

127

Sixth [abducent] nerve palsy

13.07

74.92

1.1

3.52

4.13

nmol/l

0.09

Anxiety disorders

542

1557

2.44

74.54

1.1

3.43

5.30

nmol/l

0.42

315

Other specific joint derangements/joint disorders

453

1100

2.68

73.60

1.1

1.57

6.03

nmol/l

1.77

222

Pain in throat and chest

479

1104

2.62

73.09

1.1

6.28

5.49

nmol/l

0.12

220

Dyspnoea

530

1624

2.42

73.06

1.1

4.40

5.62

nmol/l

0.31

102

314

Neurotic, stress-related and somatoform disorders

535

1551

2.43

72.86

1.1

3.43

5.32

nmol/l

0.42

312

ILD medications: prednisolone, methylprednisolone, prednisone

621

1505

2.32

72.15

1.1

6.36

3.13

nmol/l

1.03

156

243

Parkinson's disease, excluding more controls

9.43

71.84

1.0

1.1

1.07

0.17

nmol/l

0.49

Lower back pain or/and sciatica

605

1733

2.29

71.34

1.1

2.30

5.93

nmol/l

1.79

113

341

Heterophoria

106

150

7.26

71.20

1.1

0.81

7.57

nmol/l

1.29

Oral corticosteroids

600

1560

2.29

69.12

1.1

6.13

3.58

nmol/l

0.77

152

259

Nerve, nerve root and plexus disorders

602

1627

2.28

68.88

1.1

3.17

5.91

nmol/l

0.97

119

316

Other intervertebral disc disorders

461

1082

2.58

68.34

1.1

2.81

6.78

nmol/l

1.28

229

Intermittent heterotropia

9.10

68.00

1.2

1.1

0.55

3.98

nmol/l

0.50

Parkinson's disease, strict definition, excluding more controls

9.20

67.71

1.0

1.1

1.16

0.17

nmol/l

0.49

Disorders of lacrimal system

264

823

3.23

66.86

1.1

5.93

6.67

nmol/l

0.08

150

Sciatica+with lumbago

306

948

2.99

66.85

1.1

2.06

7.19

nmol/l

1.58

203

Pain, not elsewhere classified

184

454

4.09

66.44

1.1

2.77

10.55

nmol/l

1.20

Condition for Implicit Sepsis (Organ dysfunction codes)

519

1526

2.36

66.19

1.1

2.72

5.82

nmol/l

1.03

309

Spondylopathies

431

988

2.62

65.79

1.1

2.49

7.36

nmol/l

1.64

214

Mood disorders, excluding more controls

524

1324

2.37

65.38

1.1

1.42

6.37

nmol/l

2.90

274

Fibromyalgia

109

174

6.41

65.34

1.1

0.10

13.75

nmol/l

0.79

Autoimmune diseases

580

1287

2.30

64.55

1.1

7.17

1.98

nmol/l

1.69

165

178

Used for control exclusion in common control thyroid runs

545

1169

2.37

64.26

1.1

7.53

2.18

nmol/l

1.50

150

158

Inflammatory bowel disease treatment related agents

628

1614

2.19

63.76

1.1

6.50

3.54

nmol/l

0.91

169

262

Vertical strabismus

11.53

62.77

1.2

1.1

3.71

1.81

nmol/l

0.35

Other special examinations and investigations of persons without complaint or reported diagnosis

330

551

3.05

62.21

1.1

3.42

9.31

nmol/l

1.28

134

Depression

544

1648

2.25

62.06

1.1

2.36

5.81

nmol/l

1.39

330

Other antidepressants

547

1219

2.31

61.47

1.1

3.68

6.97

nmol/l

0.92

253

Migraine without aura

150

341

4.45

60.41

1.1

0.65

7.86

nmol/l

0.88

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

178

186

4.82

60.35

1.1

4.18

10.70

nmol/l

0.37

ILD medications

609

1528

2.17

60.28

1.1

6.80

3.13

nmol/l

1.18

168

244

Care involving use of rehabilitation procedures

385

1418

2.51

60.27

1.1

1.27

4.87

nmol/l

3.81

297

Dorsopathies

534

1182

2.31

59.73

1.1

2.93

6.92

nmol/l

1.31

246

Migraine with aura

169

427

4.00

59.15

1.1

0.88

6.80

nmol/l

0.92

Symptoms and signs involving the circulatory and respiratory systems

522

1144

2.30

57.59

1.1

4.68

5.44

nmol/l

0.13

104

222

ILD medications: azathioprine

134

293

4.64

56.77

1.1

12.79

10.55

nmol/l

0.12

Mood disorders

557

1687

2.15

56.24

1.1

2.46

5.74

nmol/l

1.30

337

First line medication for Crohn's disease

589

1496

2.14

56.15

1.1

6.16

4.25

nmol/l

0.48

147

255

Condition for Implicit Sepsis (Organ dysfunction codes)

475

1484

2.27

56.10

1.1

2.45

5.94

nmol/l

1.34

298

Mood [affective] disorders

555

1687

2.14

55.79

1.1

2.46

5.74

nmol/l

1.30

337

Sleep apnoea

508

1495

2.21

55.15

1.1

4.72

5.66

nmol/l

0.19

100

282

Recurrent or chronic depression

232

501

3.28

54.92

1.1

1.59

8.03

nmol/l

1.27

108

Azathioprine

134

302

4.50

54.68

1.1

12.79

10.58

nmol/l

0.11

Other and unspecified myopathies

146

6.37

54.32

1.1

4.45

0.11

nmol/l

0.79

Other/unspecified dorsalgia

218

685

3.18

53.96

1.1

2.15

8.28

nmol/l

1.67

159

Abnormalities of heart beat

211

652

3.20

52.59

1.1

3.60

7.10

nmol/l

0.46

129

Persons encountering health services for specific procedures and health care

575

1667

2.08

52.48

1.1

6.95

4.61

nmol/l

0.23

351

Symptoms and signs involving the digestive system and abdomen

503

1133

2.23

52.23

1.1

5.41

6.49

nmol/l

0.20

229

Sleep disorders (combined)

577

1452

2.09

51.93

1.1

4.62

5.68

nmol/l

0.24

125

266

Implicit Sepsis

446

1460

2.24

51.73

1.1

2.64

6.02

nmol/l

1.19

291

Sleep apnoea, including avohilmo

527

1541

2.13

51.58

1.1

4.77

5.41

nmol/l

0.13

295

Third [oculomotor] nerve palsy

14.79

51.52

1.0

1.1

4.31

1.18

nmol/l

—

Somatoform disorder

140

344

4.13

51.07

1.1

0.59

9.96

nmol/l

1.34

Soft tissue disorders

512

1211

2.18

50.95

1.1

3.11

6.59

nmol/l

1.04

253

Spondylosis

289

879

2.70

50.89

1.1

3.40

7.90

nmol/l

1.12

191

Fourth [trochlear] nerve palsy

12.92

50.85

1.1

1.68

5.32

nmol/l

—

Pain (limb, back, neck, head abdominally)

344

658

2.63

50.24

1.1

5.49

9.29

nmol/l

0.57

147

STROKE

322

858

2.57

49.15

1.1

2.41

6.90

nmol/l

1.32

179

Systemic connective tissue disorders

224

772

2.93

48.14

1.1

2.37

7.62

nmol/l

1.21

159

Anxiety (asthma-related co-morbidities)

343

1102

2.42

47.93

1.1

2.98

6.64

nmol/l

0.74

209

Other degenerative diseases of the nervous system

120

189

4.77

47.86

1.0

1.1

3.01

0.43

nmol/l

0.79

Cerebrovascular diseases (FINNGEN)

204

448

3.25

47.71

1.1

2.38

10.00

nmol/l

1.10

Persons encountering health services for examination and investigation

300

551

2.74

47.34

1.1

4.68

9.31

nmol/l

0.80

134

All anxiety disorders

347

1155

2.39

47.26

1.1

2.95

5.78

nmol/l

0.58

229

Depression or dysthymia

337

738

2.53

47.22

1.1

1.62

8.32

nmol/l

2.35

161

Other systemic involvement of connective tissue (FG)

171

501

3.40

47.16

1.1

2.98

8.77

nmol/l

0.83

102

Asthma (mode)

402

932

2.32

46.48

1.1

4.56

6.50

nmol/l

0.30

163

Asthma (only as main-diagnosis), excluding more controls

369

890

2.38

46.05

1.1

5.68

5.58

nmol/l

0.01

160

Other symptoms and signs involving cognitive functions and awareness

250

842

2.72

46.04

1.1

1.62

8.51

nmol/l

2.62

181

Asthma, excluding more controls

396

890

2.33

45.89

1.1

4.58

5.58

nmol/l

0.14

160

Asthma

403

925

2.29

45.18

1.1

4.48

6.50

nmol/l

0.31

163

Asthma (only as main-diagnosis)

373

925

2.34

45.17

1.1

5.68

6.50

nmol/l

0.10

163

Tramadol

413

1149

2.22

44.80

1.1

2.16

6.86

nmol/l

1.76

226

Postprocedural disorders of nervous system

148

5.73

44.56

1.1

0.14

6.21

nmol/l

0.95

Anaemias

127

191

4.37

43.45

1.1

0.62

6.04

nmol/l

0.97

Other general symptoms and signs

8.59

43.40

1.1

1.2

0.13

8.82

nmol/l

1.22

Lumbar disc prolapse

320

1036

2.38

43.13

1.1

2.58

6.87

nmol/l

1.43

220

Finngen Rheumatological endpoints

491

1368

2.05

42.88

1.1

4.87

5.62

nmol/l

0.14

268

Opioids

496

1256

2.06

42.79

1.1

3.19

6.83

nmol/l

1.18

245

Spinal stenosis

256

741

2.64

42.59

1.1

1.0

2.45

8.16

nmol/l

1.68

160

Codeine

472

1238

2.08

42.32

1.1

3.62

6.88

nmol/l

1.01

243

Dystonia

118

6.27

42.22

1.1

10.18

1.54

nmol/l

0.39

Implicit Sepsis

389

1366

2.16

41.49

1.1

2.28

6.53

nmol/l

1.56

275

Blepharochalasis

161

506

3.21

40.69

1.1

7.10

7.81

nmol/l

0.06

Other extrapyramidal and movement disorders in other diseases

159

500

3.21

40.20

1.1

4.81

9.04

nmol/l

0.36

107

Other reaction to severe stress, and adjustment disorders

213

790

2.71

39.95

1.1

3.40

6.84

nmol/l

0.51

165

Migraine without aura and triptan purchases

123

330

3.77

39.77

1.1

0.76

2.98

nmol/l

0.77

Disorders of refraction and accommodation

161

511

3.16

39.74

1.1

1.38

8.40

nmol/l

1.34

105

Hypothyroidism (congenital or acquired)

139

201

3.93

39.47

1.1

1.81

6.04

nmol/l

0.63

Other joint disorders

442

1125

2.08

39.38

1.1

3.19

5.90

nmol/l

0.62

227

Infections, IBD-co-morbidities

7.53

39.23

1.0

1.1

0.42

0.13

nmol/l

—

Other and unspecified visual disturbances

156

5.21

38.92

1.1

6.25

7.56

nmol/l

0.09

Other diseases of intestines

529

1572

1.92

38.68

1.1

6.18

5.00

nmol/l

0.14

104

297

Metabolic disorders

477

1476

1.98

38.66

1.1

3.61

5.48

nmol/l

0.62

290

Cervicobrachial syndrome

138

409

3.40

38.39

1.1

0.45

10.44

nmol/l

1.77

Asthma, unspecified (mode), excluding more controls

268

832

2.42

37.39

1.1

5.87

5.68

nmol/l

0.02

153

Cerebral cysts

116

5.91

37.15

1.1

0.25

5.80

nmol/l

—

Hypothyroidism, levothyroxine purchases

135

201

3.82

37.01

1.1

1.99

6.04

nmol/l

0.59

Hypothyroidism and >3 levothyroxin purchases

135

201

3.82

37.01

1.1

1.99

6.04

nmol/l

0.59

Other systemic involvement of connective tissue

173

601

2.90

36.81

1.1

2.98

8.15

nmol/l

0.83

122

Any mental disorder

517

1350

1.92

36.80

1.1

2.51

6.55

nmol/l

1.53

277

Fever of other and unknown origin

250

918

2.43

36.73

1.1

2.10

9.03

nmol/l

2.49

184

Disorders of the thyroid gland

468

1573

1.94

36.67

1.1

4.94

5.60

nmol/l

0.12

299

Codeine or tramadol medication

552

1626

1.86

36.59

1.1

3.13

5.83

nmol/l

1.06

104

319

Hypothyroidism, strict autoimmune

336

1008

2.20

36.58

1.1

5.12

2.48

nmol/l

0.44

140

Other anxiety disorders

250

895

2.43

36.45

1.1

1.10

6.51

nmol/l

1.83

177

Asthma, unspecified (mode)

271

863

2.38

36.34

1.1

5.87

6.65

nmol/l

0.09

156

Persons encountering health services for other counselling and medical advice, not elsewhere classified

539

1573

1.87

35.96

1.1

2.92

5.56

nmol/l

0.92

105

298

Other sleep disorders

160

4.93

35.80

1.1

1.87

7.66

nmol/l

1.34

Migraine with aura and triptan purchases

115

317

3.67

35.80

1.1

0.14

4.29

nmol/l

1.32

Syncope and collapse

210

693

2.61

35.30

1.1

4.06

9.03

nmol/l

0.92

147

Abdominal and pelvic pain

448

1133

1.99

35.27

1.1

3.83

6.49

nmol/l

0.65

229

ILD medications: immunosuppressive drugs

316

1370

2.15

35.07

1.1

9.67

3.22

nmol/l

1.76

102

219

Cerebrovascular diseases

356

1198

2.10

34.91

1.1

3.61

6.71

nmol/l

0.90

241

Depression medications

146

208

3.55

34.66

1.1

0.91

6.03

nmol/l

0.89

Voice disturbances

169

600

2.84

34.59

1.1

7.93

8.16

nmol/l

0.02

121

Asthma, including avohilmo

566

1767

1.80

34.18

1.1

5.34

4.93

nmol/l

0.07

114

335

Asthma (diagnoses ohter than nonallergic)

428

1864

1.91

33.59

1.1

3.90

5.33

nmol/l

0.38

358

Antihypertensive medication - note that there are other indications

313

745

2.24

33.43

1.1

3.42

3.67

nmol/l

0.03

148

Any gastric operation

387

944

2.06

33.43

1.1

8.61

5.48

nmol/l

0.28

186

GASTRO-related operations

387

944

2.06

33.43

1.1

8.61

5.48

nmol/l

0.28

186

Shoulder lesions

353

1034

2.08

32.62

1.1

1.99

7.02

nmol/l

2.12

221

Diseases of the musculoskeletal system and connective tissue

246

501

2.47

32.13

1.1

5.01

9.52

nmol/l

0.51

Obesity related asthma

201

811

2.50

31.91

1.1

2.53

8.01

nmol/l

1.31

158

Persons encountering health services in other circumstances, wide

545

1577

1.78

31.14

1.1

3.58

5.62

nmol/l

0.61

110

299

Other disorders of eye and adnexa

110

324

3.44

31.06

1.1

0.62

11.18

nmol/l

1.30

Hypothyroidism, other/unspecified

423

1472

1.90

31.00

1.1

4.41

5.63

nmol/l

0.26

280

Other disorders of binocular movement

9.18

30.87

1.2

1.0

0.41

0.10

nmol/l

—

Other pulmonary diagnosis

375

935

2.02

30.54

1.1

3.70

7.25

nmol/l

0.76

167

Selective serotonin reuptake inhibitors

441

1220

1.89

30.42

1.1

3.08

6.97

nmol/l

1.29

253

Ischaemic Stroke, excluding all haemorrhages

262

880

2.23

30.29

1.1

3.82

7.36

nmol/l

0.78

184

Triptan medication for migraine, single purchase ok

383

1348

1.93

29.84

1.1

1.55

5.93

nmol/l

2.00

261

Migraine, single triptan purchase ok & required. ICD-code if available is included

383

1348

1.93

29.84

1.1

1.55

5.93

nmol/l

2.00

261

ILD differential diagnosis

371

932

2.00

29.63

1.1

2.99

6.50

nmol/l

0.85

163

Personality disorders, excluding more controls

136

467

2.93

29.62

1.1

0.82

8.19

nmol/l

1.38

COPD differential diagnosis

371

933

2.00

29.55

1.1

2.99

6.50

nmol/l

0.85

163

Cardiovascular diseases

298

745

2.16

29.48

1.1

3.05

4.21

nmol/l

0.20

143

Excluding asthma or asthma-COPD overlap

371

935

1.99

29.38

1.1

2.99

7.25

nmol/l

1.07

167

Factors influencing health status and contact with health services

132

197

3.38

29.35

1.1

3.86

9.09

nmol/l

0.86

229

1010

2.26

29.15

1.1

4.39

6.85

nmol/l

0.48

206

Temporomandibular joint disorders, including avohilmo

244

1102

2.19

28.86

1.1

3.38

5.84

nmol/l

0.50

223

Transient ischemic attack

241

876

2.24

28.76

1.0

1.1

2.73

7.11

nmol/l

1.23

187

Cervicalgia

116

372

3.14

28.52

1.1

1.12

11.12

nmol/l

1.69

Psychiatric diseases

437

1180

1.86

28.35

1.1

4.76

6.00

nmol/l

0.24

244

Asthma, hospital admission 2, infections

286

1373

2.05

28.29

1.1

4.98

5.99

nmol/l

0.18

270

Asthma-related infections

286

1373

2.05

28.29

1.1

4.98

5.99

nmol/l

0.18

270

Rheumatism, unspecified

252

3.65

28.24

1.1

4.31

11.90

nmol/l

0.49

Cough

189

740

2.43

28.11

1.0

1.1

1.08

7.29

nmol/l

1.77

148

Hypothyreosis and Thyroxine purchase for inclusion criteria

432

1560

1.82

28.05

1.1

4.36

5.60

nmol/l

0.27

305

Arthropathies

417

1127

1.88

28.05

1.1

4.29

5.90

nmol/l

0.30

227

Acute upper respiratory infections of multiple and unspecified sites

362

1408

1.91

27.97

1.1

3.13

5.52

nmol/l

0.60

274

Parasetamol

348

884

2.00

27.94

1.1

5.35

5.31

nmol/l

0.01

179

Use of levodopa decarboxylase inhibitor

255

3.61

27.77

1.1

1.13

13.55

nmol/l

1.54

Chronic lower respiratory diseases

558

1748

1.70

27.56

1.1

5.29

4.75

nmol/l

0.10

108

335

Small fibre neuropathy

6.85

27.37

1.1

2.13

4.37

nmol/l

—

Cardiovascular diseases (excluding rheumatic etc)

311

878

2.04

27.36

1.1

4.15

5.65

nmol/l

0.20

167

Cardiac arrhythmias

302

969

2.03

26.99

1.1

2.95

6.15

nmol/l

0.70

193

Asthma, hospital admissions , main diagnosis only

389

1885

1.83

26.95

1.1

5.71

4.95

nmol/l

0.13

350

Non-invasive ventilation

121

362

3.00

26.85

1.1

1.35

10.16

nmol/l

1.07

Symptoms and signs involving the urinary system

353

1425

1.89

26.68

1.1

4.38

5.56

nmol/l

0.28

296

Stroke, excluding SAH

266

928

2.10

26.63

1.1

4.21

6.98

nmol/l

0.57

193

Generalized anxiety disorder

302

3.31

26.47

1.1

0.78

3.58

nmol/l

1.03

Parkinson's disease, including avohilmo

287

3.34

25.83

1.0

1.1

0.94

12.70

nmol/l

1.64

Other and unspecified myoneural disorders

43.92

25.59

1.2

30.40

—

nmol/l

—

Follow-up examination after treatment for conditions other than malignant neoplasms

174

462

2.50

25.45

1.1

2.03

9.67

nmol/l

1.65

119

Benzodiazepine use

465

1861

1.72

25.42

1.1

1.86

5.66

nmol/l

2.17

372

Nausea and vomiting

131

470

2.75

25.28

1.1

1.49

8.20

nmol/l

1.32

108

Disorders of vestibular function (Vertigo)

231

1076

2.12

25.18

1.1

1.17

6.92

nmol/l

2.82

218

Diseases of oesophagus, stomach and duodenum

484

1698

1.71

24.88

1.1

4.57

4.92

nmol/l

0.06

340

Nonorganic sleeping disorders, excluding more controls

107

357

3.02

24.64

1.1

0.34

10.73

nmol/l

1.49

Other disorders of urethra and urinary system

328

1258

1.89

24.38

1.1

6.79

5.77

nmol/l

0.13

242

L04AX Other immunosuppressants

273

1392

1.97

24.36

1.1

10.32

3.80

nmol/l

1.66

247

Hard cardiovascular diseases

375

1226

1.83

24.25

1.1

5.26

5.71

nmol/l

0.07

245

Autoimmune diseases related-to ILD

392

1908

1.76

24.09

1.1

5.31

4.99

nmol/l

0.05

376

Acute upper respiratory infections

467

1690

1.71

24.07

1.1

2.13

5.77

nmol/l

1.91

326

Hypertensive diseases (excluding secondary)

248

690

2.10

23.45

1.1

3.64

7.16

nmol/l

0.45

129

Second line medication for Crohn's disease

278

1446

1.93

23.42

1.1

10.21

3.65

nmol/l

1.72

258

Pain and other conditions associated with female genital organs and menstrual cycle

118

390

2.80

23.31

1.1

0.69

4.29

nmol/l

1.27

Dentofacial anomalies [including malocclusion]

333

1460

1.84

23.26

1.1

3.79

5.37

nmol/l

0.36

284

Any reimbursement code in KELA

268

655

2.06

23.22

1.1

5.40

1.04

nmol/l

1.36

103

Vocal cord dysfunction

179

3.74

23.21

1.1

15.86

15.18

nmol/l

—

Enthesopathies of lower limb, excluding foot

115

413

2.80

23.21

1.1

1.00

10.23

nmol/l

1.67

Rotator cuff syndrome

265

956

2.00

23.13

1.1

2.46

7.32

nmol/l

1.79

209

Bronchitis

484

1831

1.67

23.11

1.1

4.13

5.23

nmol/l

0.26

100

346

505

1567

1.67

23.08

1.1

3.03

5.67

nmol/l

0.95

104

294

Coxibs

130

239

2.88

23.04

1.1

1.0

5.53

6.39

nmol/l

0.10

Symptoms and signs concerning food and fluid intake

147

4.18

22.98

1.1

0.12

19.69

nmol/l

—

Disorders of muscles

178

3.86

22.97

1.1

1.16

15.92

nmol/l

1.24

Cerebral palsy and other paralytic syndromes

231

3.46

22.68

1.1

0.51

7.02

nmol/l

1.83

Diseases of inner ear

253

1247

1.97

22.54

1.1

1.33

7.09

nmol/l

3.17

254

Cervical disc disorders

160

686

2.34

22.37

1.1

2.17

8.75

nmol/l

1.70

156

Stroke, including SAH

267

991

1.96

22.27

1.1

4.07

7.09

nmol/l

0.66

203

Parkinson's disease

279

3.18

22.18

1.0

1.1

1.07

12.88

nmol/l

1.61

Other diseases of the respiratory system

107

380

2.84

22.08

1.1

3.86

11.40

nmol/l

0.94

Other respiratory disorders and diseases

107

380

2.84

22.08

1.1

3.86

11.40

nmol/l

0.94

Parkinson's disease, strict definition

261

3.25

21.90

1.0

1.1

1.16

13.68

nmol/l

1.60

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

174

781

2.24

21.87

1.0

1.1

4.19

6.21

nmol/l

0.23

155

COPD/asthma/ILD related infections

461

1371

1.69

21.84

1.1

2.71

5.74

nmol/l

1.04

257

COPD/asthma related infections

461

1371

1.69

21.84

1.1

2.71

5.74

nmol/l

1.04

257

Disorders of lipoprotein metabolism and other lipidaemias

358

1243

1.79

21.79

1.1

3.88

6.15

nmol/l

0.67

250

Gastro-oesophageal reflux disease

309

1460

1.83

21.69

1.0

1.1

6.52

5.24

nmol/l

0.19

293

Cramp and spasm

105

4.77

21.55

1.1

0.13

3.01

nmol/l

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

244

1217

1.96

21.33

1.1

4.94

5.86

nmol/l

0.14

241

Asthma/COPD (KELA code 203)

427

1747

1.68

21.32

1.1

5.72

4.75

nmol/l

0.15

335

Diseases of the ear and mastoid process

511

1578

1.63

21.22

1.1

2.24

6.18

nmol/l

1.87

106

305

Implicit viral Sepsis

145

612

2.38

21.04

1.1

4.38

9.34

nmol/l

0.58

130

Use of pramipexole

121

470

2.59

21.01

1.1

5.46

9.48

nmol/l

0.40

101

Oxicams

110

213

2.95

20.90

1.1

1.0

7.93

6.91

nmol/l

0.07

Gastrointestinal diseases

266

675

1.98

20.89

1.1

5.19

6.36

nmol/l

0.17

122

Hypothyroidism, drug reimbursement

132

3.77

20.66

1.0

1.1

1.39

7.96

nmol/l

—

Intestinal infectious diseases

503

1787

1.61

20.61

1.1

4.66

5.23

nmol/l

0.11

101

337

Disorders of conjunctiva

374

1760

1.71

20.56

1.1

6.55

4.42

nmol/l

0.36

319

Endocrine, nutritional and metabolic diseases

352

1002

1.78

20.28

1.1

5.34

5.66

nmol/l

0.04

195

Sequelae of cerebrovascular disease

155

587

2.29

19.98

1.1

5.12

8.36

nmol/l

0.36

128

Behavioural syndromes associated with physiological disturbances and physical factors

412

1761

1.66

19.98

1.1

4.18

5.02

nmol/l

0.14

340

Respiratory insufficiency

107

4.52

19.98

1.0

1.1

0.34

26.66

nmol/l

1.08

Diseases of the respiratory system

282

743

1.91

19.95

1.1

4.76

6.74

nmol/l

0.27

135

Thyrotoxicosis, other and/or unspecified

109

414

2.65

19.83

1.0

1.1

6.39

7.85

nmol/l

0.09

Chronic rhinitis, nasopharyngitis and pharyngitis

159

717

2.23

19.81

1.1

1.59

8.05

nmol/l

1.80

150

Non-selective monoamine reuptake inhibitors

167

739

2.19

19.76

1.1

1.25

8.93

nmol/l

2.64

161

Disorders of other endocrine glands

204

999

2.02

19.58

1.1

1.42

6.46

nmol/l

1.94

200

Sleep disorders

393

1708

1.67

19.31

1.1

4.34

5.03

nmol/l

0.11

327

Triptan medication for migraine, min. 3 purchases

273

1135

1.84

19.15

1.1

1.41

5.79

nmol/l

1.56

212

Constipation

383

1584

1.68

19.14

1.1

6.93

5.11

nmol/l

0.13

318

Autonomic disorders

6.35

19.03

1.1

0.48

1.09

nmol/l

—

Oedema, not elsewhere classified

134

564

2.35

18.98

1.0

1.1

3.14

9.76

nmol/l

1.35

121

Dermatitis and eczema

479

1874

1.59

18.85

1.1

2.76

5.59

nmol/l

1.31

362

Other functional intestinal disorders

200

928

2.01

18.78

1.1

0.53

6.21

nmol/l

4.82

185

Brachial plexus disorders

215

3.29

18.68

1.1

1.24

4.66

nmol/l

0.77

Disorders of synovium and tendon

220

995

1.94

18.65

1.1

2.10

6.82

nmol/l

1.50

210

Pain in thoracic spine

277

2.98

18.61

1.1

10.42

12.65

nmol/l

0.10

Hypertension, essential

349

1147

1.73

18.58

1.1

6.75

5.62

nmol/l

0.15

223

Other diseases of urinary system

431

1491

1.63

18.43

1.1

4.32

5.52

nmol/l

0.25

279

Hypermobility syndrome

116

4.21

18.18

1.1

0.14

8.49

nmol/l

0.86

Hypothyroidism, strict autoimmune, 3 medication purchases required

362

1458

1.68

18.17

1.1

5.01

5.67

nmol/l

0.12

288

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

422

1810

1.61

18.06

1.1

2.87

5.77

nmol/l

1.32

347

Certain infectious and parasitic diseases

429

1320

1.63

18.00

1.1

3.75

5.67

nmol/l

0.50

245

Other heart diseases

206

673

2.01

18.00

1.1

3.91

6.97

nmol/l

0.38

132

Complications of surgical and medical care, not elsewhere classified

427

1827

1.60

17.91

1.1

2.89

5.65

nmol/l

0.85

363

Benign neoplasm of meninges

207

3.27

17.73

1.2

1.1

9.48

12.16

nmol/l

0.10

Dermatitis

270

1520

1.78

17.63

1.1

2.60

5.66

nmol/l

1.25

302

Other and unspecified dermatitis

227

1217

1.87

17.62

1.1

2.24

6.16

nmol/l

1.53

251

Exclusions for E4_PCOS_BROAD

381

2.62

17.58

1.1

1.47

10.77

nmol/l

1.32

Bell's palsy

234

3.11

17.51

1.1

4.45

11.86

nmol/l

0.55

Diarrhoea and gastroenteritis of presumed infectious origin

434

1806

1.59

17.34

1.1

4.51

5.24

nmol/l

0.13

338

Pure hypercholesterolaemia

302

1132

1.75

17.28

1.1

3.71

6.58

nmol/l

0.83

231

Carpal tunnel syndrome

260

1281

1.79

17.27

1.1

4.74

6.14

nmol/l

0.21

252

Irritable bowel syndrome

136

610

2.24

17.25

1.1

1.21

5.11

nmol/l

2.06

124

Benign neoplasm: Cerebral meninges

191

3.34

17.20

1.1

10.20

13.18

nmol/l

0.11

Other arrhythmias

284

1222

1.76

17.14

1.1

1.83

6.14

nmol/l

1.78

224

Other heart diseases, wide

401

1518

1.62

17.11

1.1

3.23

5.38

nmol/l

0.58

280

Intestinal infectious diseases

405

1927

1.60

17.08

1.1

4.98

5.05

nmol/l

0.01

367

Atypical facial pain

113

4.14

17.08

1.2

1.1

0.48

3.68

nmol/l

—

Conjunctivitis

331

1655

1.67

17.07

1.1

6.98

4.65

nmol/l

0.37

298

Disorders of orbit

4.89

16.87

1.1

1.33

1.70

nmol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

118

504

2.34

16.62

1.1

4.74

7.71

nmol/l

0.23

106

Allergic asthma (mode), excluding more controls

108

435

2.44

16.62

1.1

1.08

8.86

nmol/l

1.10

Implicit viral Sepsis

388

2.54

16.47

1.1

0.53

12.16

nmol/l

2.14

Viral Sepsis

388

2.54

16.47

1.1

0.53

12.16

nmol/l

2.14

Allergic asthma (mode)

108

437

2.43

16.46

1.1

1.08

9.99

nmol/l

1.30

Use of hypnotics and sedatives

456

1688

1.55

16.22

1.1

3.37

5.28

nmol/l

0.37

341

Other inflammation of eyelid

245

2.96

16.20

1.1

5.64

11.40

nmol/l

0.29

Myopia

240

2.98

16.16

1.1

2.31

7.39

nmol/l

0.85

Post-traumatic stress disorder

145

3.62

16.14

1.0

1.1

0.64

6.20

nmol/l

—

Polyuria

107

446

2.41

16.12

1.1

3.71

9.82

nmol/l

0.84

Codes for special purposes

232

1289

1.80

16.01

1.1

1.76

6.66

nmol/l

2.33

262

Provisional assignment of new diseases of uncertain etiology

232

1289

1.80

16.01

1.1

1.76

6.66

nmol/l

2.33

262

Traumatic subdural haemorrhage

4.42

15.76

1.1

10.65

0.15

nmol/l

—

Deforming dorsopathies

115

500

2.31

15.74

1.1

1.76

8.99

nmol/l

1.59

115

Enlarged lymph nodes

249

2.91

15.73

1.1

0.45

15.99

nmol/l

1.70

Benign neoplasms

413

1443

1.58

15.70

1.1

4.12

5.27

nmol/l

0.24

268

Disorders of adult personality and behaviour

141

670

2.12

15.53

1.1

1.12

5.21

nmol/l

1.99

130

Faecal incontinence

154

3.47

15.48

1.0

1.1

1.25

13.54

nmol/l

—

Other CVD (FINNGEN)

144

3.31

15.46

1.1

1.82

16.44

nmol/l

0.62

Astigmatism

108

4.03

15.46

1.0

1.1

0.31

2.58

nmol/l

—

Hypertensive diseases

342

1175

1.65

15.42

1.1

6.50

5.56

nmol/l

0.12

226

Other symptoms and signs involving the digestive system and abdomen

308

2.68

15.36

1.1

0.31

9.62

nmol/l

1.30

Thyrotoxicosis

126

576

2.20

15.33

1.0

1.1

6.11

7.42

nmol/l

0.09

116

Hypertension

341

1173

1.64

15.29

1.1

6.50

5.56

nmol/l

0.12

226

Dissociative [conversion] disorders

4.80

15.21

1.1

0.11

5.26

nmol/l

—

Certain infectious and parasitic diseases

316

940

1.69

15.19

1.1

9.69

4.87

nmol/l

0.42

171

Oter anti-inflammatory and antirheumatic agents, non-steroids

194

2.69

15.18

1.1

1.0

7.60

7.68

nmol/l

0.01

Oxycodone

157

704

2.02

15.16

1.1

3.44

9.48

nmol/l

0.91

137

363

1371

1.61

15.07

1.1

5.30

5.74

nmol/l

0.07

257

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

363

1371

1.61

15.07

1.1

5.30

5.74

nmol/l

0.07

257

Other enthesopathies

128

594

2.16

15.00

1.0

1.1

1.69

8.73

nmol/l

1.79

136

Radiculopathy

278

2.75

14.99

1.1

0.20

12.31

nmol/l

—

Other nutritional deficiencies

289

1638

1.67

14.96

1.1

2.03

6.06

nmol/l

1.84

311

Personality disorders

136

647

2.11

14.96

1.1

0.82

4.76

nmol/l

2.04

128

Demyelinating diseases of the central nervous system

199

3.10

14.83

1.0

1.1

3.99

5.98

nmol/l

0.21

Covid-19 confirmed case

158

797

1.99

14.81

1.1

2.05

7.81

nmol/l

1.72

163

Insomnia

367

1696

1.58

14.74

1.1

4.52

5.09

nmol/l

0.08

317

Other degenerative diseases of the basal ganglia

6.54

14.66

1.0

1.2

—

9.73

nmol/l

—

Other diseases of upper respiratory tract

449

1533

1.53

14.63

1.1

4.29

6.11

nmol/l

0.47

290

Hyperkinetic disorders, excluding more controls

166

3.25

14.63

1.1

0.15

6.55

nmol/l

—

Continuous positive airway pressure

272

2.61

14.49

1.0

1.1

2.33

11.88

nmol/l

0.88

Nonorganic sleeping disorders

107

469

2.30

14.44

1.1

0.34

5.82

nmol/l

2.65

Autoimmune hyperthyroidism

105

3.95

14.41

1.1

0.82

0.10

nmol/l

—

Diarrhoea and gastroenteritis of presumed infectious origin

298

1642

1.64

14.41

1.1

6.05

5.06

nmol/l

0.13

324

Intracranial injury

239

1307

1.73

14.40

1.1

3.46

7.01

nmol/l

0.86

272

Spasmodic torticollis

4.68

14.29

1.1

0.12

0.81

nmol/l

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

266

1418

1.68

14.24

1.1

6.32

5.60

nmol/l

0.11

281

Cystitis

354

1323

1.59

14.23

1.1

4.87

5.68

nmol/l

0.13

246

Ocular pain

194

3.08

14.17

1.1

0.44

7.39

nmol/l

1.34

Caries of dentine

103

435

2.31

14.14

1.1

1.66

8.36

nmol/l

1.08

Osteoporosis with pathological fracture (FG)

111

3.82

14.13

1.0

1.1

1.85

16.25

nmol/l

—

Implicit bacterial Sepsis

165

758

1.94

14.03

1.1

3.56

8.38

nmol/l

0.99

152

Certain disorders involving the immune mechanism

420

2.35

13.95

1.1

1.85

10.28

nmol/l

1.24

Persistent mood disorders

396

2.39

13.90

1.1

1.37

11.03

nmol/l

1.59

Injuries to the head

458

1888

1.49

13.88

1.1

2.80

5.53

nmol/l

1.11

372

Implicit bacterial Sepsis

179

827

1.88

13.78

1.1

3.32

8.16

nmol/l

1.12

167

Injury, poisoning and certain other consequences of external causes

236

667

1.78

13.65

1.1

3.10

7.21

nmol/l

1.41

137

Restless leg syndrome

304

2.59

13.65

1.1

7.84

11.05

nmol/l

0.14

Specific personality disorders

118

552

2.15

13.61

1.0

1.1

0.77

3.34

nmol/l

1.56

106

Acetic acid derivatives and related substances

108

237

2.37

13.48

1.2

1.0

7.53

6.39

nmol/l

0.08

Hemiplegia

106

3.83

13.44

1.0

1.1

0.09

4.05

nmol/l

—

External causes of morbidity and mortality

285

854

1.68

13.43

1.1

2.70

8.73

nmol/l

1.64

160

Acute sinusitis

221

1180

1.74

13.43

1.0

1.1

1.12

6.13

nmol/l

2.29

232

Exposure to unspecified factor

411

1966

1.51

13.39

1.1

2.47

5.59

nmol/l

1.68

370

Hypotension

313

2.54

13.35

1.1

3.48

11.74

nmol/l

1.02

Chronic laryngitis and laryngotracheitis

273

2.66

13.31

1.1

0.58

13.39

nmol/l

1.48

Other specified/unspecified systemic involvement of connective tissue

116

3.67

13.30

1.2

1.1

0.39

6.23

nmol/l

0.64

Missing teeth due to accident, extraction or parodontitis

239

1334

1.69

13.23

1.1

3.06

6.47

nmol/l

1.29

259

Implicit fungal Sepsis

126

3.53

13.21

1.0

1.1

0.55

11.89

nmol/l

—

Persons encountering health services in other circumstances

166

882

1.88

13.18

1.1

5.68

6.39

nmol/l

0.09

180

Pain associated with micturition

236

2.78

13.08

1.0

1.1

0.40

14.73

nmol/l

1.58

Chronic sinusitis

184

1020

1.81

12.96

1.1

1.71

6.64

nmol/l

1.80

204

Blepharospasm

10.27

12.95

1.1

0.28

0.12

nmol/l

—

Convergent concomitant strabismus

105

3.76

12.82

1.1

0.12

4.34

nmol/l

—

Polyarthropathies

255

996

1.68

12.79

1.1

4.36

5.93

nmol/l

0.26

205

Obesity, other/unspecified

158

841

1.89

12.73

1.0

1.1

2.96

6.97

nmol/l

0.82

167

Dental caries

109

487

2.16

12.71

1.1

1.87

7.87

nmol/l

1.00

100

Endometriosis

152

452

1.98

12.67

1.1

6.24

4.15

nmol/l

0.25

Complications of medical and surgical care

301

1757

1.58

12.61

1.1

2.89

5.91

nmol/l

0.72

338

Special screening examination for infectious and parasitic diseases

275

2.39

12.47

1.1

2.35

13.97

nmol/l

1.22

Diagnoses used for exclusion with ILD

112

532

2.12

12.46

1.1

1.90

10.15

nmol/l

1.64

109

Paracetamol or NSAID medication

129

2.82

12.41

1.2

1.1

1.27

7.36

nmol/l

1.19

Benign paroxysmal vertigo

130

654

2.00

12.39

1.1

1.70

8.47

nmol/l

1.76

135

Other disorders of ear

369

1598

1.51

12.18

1.1

2.07

5.97

nmol/l

2.20

320

Other shoulder lesions

174

3.01

12.15

1.0

1.1

0.17

14.46

nmol/l

1.17

Other diseases of hard tissues of teeth

235

713

1.71

12.05

1.1

8.37

7.05

nmol/l

0.16

146

Bacterial Sepsis

179

858

1.79

11.89

1.1

4.00

7.96

nmol/l

0.83

172

Other and unspecified disorders of binocular movement

32.10

11.81

1.1

1.0

0.25

—

nmol/l

—

Asthma and allergy

212

2.76

11.80

1.1

1.13

16.75

nmol/l

0.95

Other CVD

357

2.34

11.78

1.0

1.1

3.13

11.83

nmol/l

1.24

Obesity and other hyperalimentation

267

1618

1.59

11.77

1.0

1.1

2.34

6.03

nmol/l

1.51

309

Sarcoidosis

285

2.51

11.75

1.1

2.30

6.07

nmol/l

0.77

Asthma and allergy, excluding more controls

213

2.75

11.70

1.1

1.13

13.62

nmol/l

0.76

Obesity

265

1609

1.59

11.66

1.0

1.1

2.37

5.92

nmol/l

1.41

307

Emotionally unstable personality disorder

281

2.51

11.59

1.1

1.09

3.92

nmol/l

0.79

Neuralgia and neuritis, unspecified

3.93

11.56

1.0

1.1

0.14

5.09

nmol/l

—

Ischemic heart diseases

324

1262

1.55

11.54

1.1

5.60

5.90

nmol/l

0.04

251

Functional dyspepsia

120

605

1.99

11.41

1.1

1.79

6.33

nmol/l

0.90

128

Complications of procedures, not elsewhere classified

325

1773

1.52

11.38

1.1

3.11

5.67

nmol/l

0.57

352

Urticaria

135

710

1.91

11.34

1.1

0.64

7.18

nmol/l

1.83

140

Diseases of the skin and subcutaneous tissue

406

1380

1.48

11.33

1.1

8.25

4.97

nmol/l

0.34

279

Panic disorder

296

2.45

11.33

1.1

15.00

4.53

nmol/l

—

Gonarthrosis [arthrosis of knee](FG)

283

1039

1.59

11.25

1.1

6.02

6.50

nmol/l

0.06

207

Urticaria and erythema

159

884

1.81

11.20

1.1

1.38

6.63

nmol/l

1.60

171

Spirochaetal infections, other/unspecified

184

2.85

11.05

1.1

1.70

14.30

nmol/l

0.86

Guillain-Barre syndrome

5.54

10.94

1.0

1.1

0.12

2.22

nmol/l

—

Speech and linguistic disorders, excluding more controls

105

3.43

10.84

1.2

1.1

4.12

5.39

nmol/l

0.09

Other disorders of fluid, electrolyte and acid-base balance

121

592

1.95

10.83

1.1

7.64

7.59

nmol/l

0.00

127

Disorders of lacrimal system and orbit in diseases classified elsewhere

4.80

10.75

1.1

1.13

0.27

nmol/l

—

Other metabolic disorders

286

2.43

10.70

1.0

1.1

3.53

12.10

nmol/l

0.70

Polymyalgia rheumatica

235

2.57

10.49

1.1

3.49

13.09

nmol/l

—

Influenza and pneumonia

420

1869

1.43

10.44

1.1

4.58

5.00

nmol/l

0.09

346

Diverticular disease of intestine

265

1078

1.57

10.39

1.1

5.11

6.05

nmol/l

0.16

211

Atrial fibrillation and flutter

120

395

1.98

10.32

1.1

5.29

8.14

nmol/l

0.21

Other disorders of patella

347

2.26

10.30

1.1

2.09

9.34

nmol/l

0.88

Anti-inflammatory and antirheumatic products, non-steroids

105

249

2.13

10.23

1.2

1.1

3.35

6.28

nmol/l

0.59

Other external causes of accidental injury

331

1102

1.51

10.21

1.1

3.05

7.78

nmol/l

1.45

201

Menorrhagia

144

429

1.87

10.15

1.1

8.19

3.04

nmol/l

0.59

Injuries to the neck

103

514

2.01

10.14

1.1

5.50

5.47

nmol/l

0.00

105

Thyrotoxicosis with diffuse goitre

294

2.36

10.09

1.1

2.77

9.93

nmol/l

0.57

Excessive, frequent and irregular menstruation

158

480

1.81

10.04

1.1

8.77

3.93

nmol/l

0.49

Neoplasms

310

1084

1.52

10.02

1.1

2.64

3.87

nmol/l

0.35

197

Cervicocranial syndrome

183

2.75

10.00

1.1

0.81

14.87

nmol/l

1.15

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

390

1858

1.43

9.95

1.1

5.12

5.03

nmol/l

0.02

350

Percutaneous Coronary Intervention

298

1205

1.52

9.95

1.1

5.88

6.10

nmol/l

0.03

241

Dental pulpitis, including avohilmo

371

1665

1.45

9.92

1.1

1.28

5.91

nmol/l

3.05

318

Bipolar affective disorders

385

2.17

9.92

1.1

0.22

5.98

nmol/l

2.44

Other diseases of pleura

169

865

1.72

9.91

1.1

2.89

7.46

nmol/l

1.19

186

Arthrosis

266

935

1.56

9.90

1.1

7.23

6.49

nmol/l

0.09

187

Accidents

329

1102

1.50

9.88

1.1

2.82

7.78

nmol/l

1.62

201

Retention of urine

129

569

1.87

9.87

1.1

1.67

9.77

nmol/l

1.85

128

Neuromuscular dysfunction of bladder

179

2.76

9.85

1.1

0.26

14.43

nmol/l

—

Disease of hard tissues of teeth, NOS

221

707

1.64

9.85

1.1

3.32

7.01

nmol/l

0.73

144

Postprocedural endocrine and metabolic disorders, not elsewhere classified

268

2.40

9.75

1.0

1.1

3.79

12.75

nmol/l

0.69

Lesion of ulnar nerve

262

2.42

9.73

1.1

3.37

12.88

nmol/l

—

Trigeminal neuralgia

116

3.22

9.73

1.2

1.1

1.02

3.67

nmol/l

—

Coronary revascularization (ANGIO or CABG)

297

1205

1.51

9.72

1.0

1.1

5.88

6.10

nmol/l

0.03

241

Osteopathies and chondropathies

217

1270

1.60

9.67

1.0

1.1

3.23

5.92

nmol/l

0.60

253

Trochanteric bursitis

263

2.41

9.66

1.1

0.94

11.54

nmol/l

—

Deviated nasal septum

130

714

1.83

9.58

1.1

2.02

7.49

nmol/l

1.36

143

Monoamine oxidase A inhibitors

228

2.52

9.58

1.1

1.17

13.15

nmol/l

—

Disorders of mineral metabolism

149

2.91

9.53

1.1

8.73

15.67

nmol/l

—

Pneumonias (Asthma/COPD co-morbidities)

395

1872

1.42

9.52

1.1

5.12

4.96

nmol/l

0.03

352

Haemorrhoids and perianal venous thrombosis

125

679

1.84

9.51

1.1

17.47

6.59

nmol/l

0.29

138

Diseases of pulp and periapical tissues, including avohilmo

412

1508

1.42

9.40

1.1

4.14

6.14

nmol/l

0.54

290

Asthma-related pneumonia

139

783

1.78

9.40

1.1

6.11

8.29

nmol/l

0.25

154

Asthma-related pneumonia or sepsis

139

783

1.78

9.40

1.1

6.11

8.29

nmol/l

0.25

154

Asthma, hospital admissions 3, pneumonia

139

783

1.78

9.40

1.1

6.11

8.29

nmol/l

0.25

154

Disorders of psychological development

212

2.51

9.38

1.2

1.1

3.33

3.02

nmol/l

0.03

Pneumonia, organism unspecified

357

1744

1.44

9.31

1.1

4.91

5.25

nmol/l

0.06

326

Epilepsy

100

508

1.97

9.30

1.0

1.1

0.37

7.78

nmol/l

1.62

106

Meniscus derangement

204

848

1.62

9.29

1.1

7.54

7.07

nmol/l

0.04

171

Exclusions for E4_PCOS_CONSORTIUM

291

1217

1.50

9.26

1.1

10.06

4.28

nmol/l

0.42

219

Lateral epicondylitis

250

2.41

9.25

1.1

1.74

12.71

nmol/l

—

Emergency coronary revascularization (for ACS)

316

1304

1.48

9.23

1.0

1.1

6.00

nmol/l

0.00

259

All pneumoniae

395

1877

1.41

9.15

1.1

5.12

4.98

nmol/l

0.03

351

Viral infections characterized by skin and mucous membrane lesions

336

1999

1.44

9.12

1.1

8.67

4.46

nmol/l

0.30

395

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

380

2.12

9.05

1.1

0.52

9.52

nmol/l

1.17

290

2.29

9.04

1.1

2.12

12.17

nmol/l

0.92

Benign neoplasm: Stomach

205

2.56

9.04

1.1

9.20

14.52

nmol/l

0.22

Spondylolisthesis/Spondylolysis

341

2.18

9.03

1.1

2.25

11.70

nmol/l

1.26

Gonarthrosis

233

845

1.57

9.03

1.1

6.85

nmol/l

0.00

173

Coxarthrosis

177

700

1.67

9.03

1.0

1.1

6.26

8.06

nmol/l

0.23

144

Mixed connective tissue disease

143

2.90

9.02

1.2

1.1

0.41

5.90

nmol/l

—

Mycoses

333

2018

1.44

9.01

1.1

4.79

5.01

nmol/l

0.04

373

Disorders of lens

248

1005

1.54

9.00

1.1

8.34

6.30

nmol/l

0.23

189

Propionic acid derivatives

101

249

2.04

8.99

1.1

2.29

6.28

nmol/l

0.91

Allergic conjunctivitis

231

1464

1.54

8.95

1.1

6.96

4.76

nmol/l

0.27

271

Other arthrosis

189

802

1.64

8.93

1.0

1.1

2.37

7.15

nmol/l

1.22

163

Benign neoplasm of colon, rectum, anus and anal canal

234

1325

1.54

8.82

1.1

1.87

6.86

nmol/l

2.63

258

Cerebral aneurysm, nonruptured

173

2.68

8.79

1.0

1.1

4.09

6.63

nmol/l

—

Hyperlipidaemia, other/unspecified

140

742

1.74

8.76

1.1

2.60

6.81

nmol/l

1.03

158

Endometriosis of pelvic peritoneum

316

2.18

8.74

1.1

0.45

3.54

nmol/l

—

Hypopituitarism

140

2.88

8.74

1.1

2.25

3.07

nmol/l

—

Postmenopausal osteoporosis with pathological fracture

119

3.06

8.70

1.0

1.1

2.01

17.24

nmol/l

—

Chronic apical periodontitis

437

1808

1.38

8.70

1.1

4.29

5.44

nmol/l

0.29

342

Other bacterial diseases

358

1699

1.42

8.68

1.1

3.02

5.54

nmol/l

1.01

337

Coxarthrosis [arthrosis of hip](FG)

189

822

1.62

8.66

1.0

1.1

7.10

7.92

nmol/l

0.10

164

Heartburn

187

2.58

8.55

1.1

10.24

14.42

nmol/l

0.17

Soft tissue disorders related to use, overuse and pressure

101

533

1.90

8.53

1.1

5.25

9.45

nmol/l

0.49

119

Diseases of pulp and periapical tissues and dental caries

255

857

1.53

8.50

1.1

5.11

7.94

nmol/l

0.52

169

Sicca syndrome [Sjögren]

183

2.59

8.41

1.1

5.08

14.27

nmol/l

0.39

Atrial fibrillation and flutter with reimbursement

309

1.98

8.39

1.0

1.1

8.13

9.59

nmol/l

0.07

Myositis

4.51

8.39

1.1

0.98

4.26

nmol/l

—

Undetermined asthma

225

2.41

8.35

1.1

2.05

18.70

nmol/l

1.28

Diseases of oral cavity, salivary glands and jaws

219

717

1.57

8.35

1.1

8.00

7.12

nmol/l

0.10

148

Mixed and other personality disorders

184

2.58

8.32

1.1

1.42

5.62

nmol/l

—

Other and unspecified effects of external causes

114

631

1.81

8.30

1.1

1.37

7.53

nmol/l

1.42

129

Mouth breathing

158

957

1.65

8.30

1.1

4.24

7.14

nmol/l

0.46

192

Non-allergic asthma (mode)

330

2.14

8.29

1.1

1.32

13.42

nmol/l

1.32

Fall on same level

445

1783

1.36

8.28

1.1

2.29

5.78

nmol/l

1.94

352

Congenital malformations, deformations and chromosomal abnormalities

255

1586

1.48

8.26

1.1

3.46

5.29

nmol/l

0.52

300

Haemorrhage from respiratory passages

114

567

1.82

8.25

1.1

1.42

7.94

nmol/l

1.42

114

Abnormal findings on diagnostic imaging of central nervous system

102

3.17

8.24

1.0

1.1

10.70

3.66

nmol/l

—

Fracture of rib(s), sternum and thoracic spine

115

640

1.80

8.23

1.1

0.19

8.96

nmol/l

2.99

140

Other enthesopathy of foot (+metatarsalgia)

185

2.56

8.22

1.0

1.1

1.88

14.72

nmol/l

—

Convulsions, not elsewhere classified

363

2.07

8.20

1.1

0.34

10.94

nmol/l

2.02

Bacterial infection, other or unspecified

209

1143

1.55

8.18

1.1

5.71

6.58

nmol/l

0.12

224

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

198

2.49

8.13

1.2

1.1

0.42

6.17

nmol/l

—

Undetermined asthma, excluding more controls

228

2.38

8.12

1.1

2.05

15.84

nmol/l

1.01

Other/unspecified enthesopathies of lower limb, excluding foot

124

2.93

8.12

1.2

1.1

2.16

8.44

nmol/l

—

Non-allergic asthma (mode), excluding more controls

333

2.12

8.11

1.1

1.32

10.82

nmol/l

1.06

Thyroiditis, ILD-related definition

260

2.28

8.08

1.0

1.1

8.48

5.90

nmol/l

—

Conjunctivitis (acute, non atopic)

112

620

1.81

8.06

1.1

6.38

7.65

nmol/l

0.09

113

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

213

1356

1.53

8.05

1.1

7.17

4.61

nmol/l

0.31

246

Inflammatory diseases of female pelvic organs

243

1193

1.50

8.04

1.1

1.12

5.59

nmol/l

1.75

224

Exposure to other specified factors

290

1854

1.44

8.00

1.1

3.09

5.32

nmol/l

0.63

360

Other and unspecified nerve root and plexus disorders, also in other diseases

406

2.00

7.98

1.1

0.16

9.60

nmol/l

1.59

Weight loss

206

2.44

7.97

1.1

0.11

7.76

nmol/l

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

307

1.99

7.95

1.1

0.57

10.11

nmol/l

0.99

Other bacterial diseases

388

1788

1.38

7.95

1.1

4.51

5.09

nmol/l

0.12

340

Ganglion

414

1.99

7.92

1.1

2.48

11.41

nmol/l

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

230

1518

1.50

7.91

1.1

3.87

6.27

nmol/l

0.36

303

Noninflammatory disorders of female genital tract

162

487

1.67

7.85

1.1

6.17

3.93

nmol/l

0.22

Dislocation, sprain and strain of joints and ligaments at neck level

348

2.08

7.85

1.2

1.1

5.18

6.43

nmol/l

0.13

Other disorders of skin and subcutaneous tissue

255

1546

1.47

7.82

1.1

2.59

6.19

nmol/l

1.22

312

Other disorders of bone

452

1.93

7.75

1.0

1.1

0.55

9.65

nmol/l

1.61

Metatarsalgia

173

2.56

7.74

1.0

1.1

1.88

13.73

nmol/l

—

Diaphragmatic hernia

137

817

1.68

7.72

1.1

3.50

7.75

nmol/l

0.82

166

Dental operations

223

747

1.54

7.70

1.1

6.37

6.34

nmol/l

0.00

163

Paroxysmal tachycardia

358

1.97

7.68

1.0

1.1

1.97

10.89

nmol/l

0.98

Abnormal weight loss

192

2.47

7.64

1.1

0.11

7.94

nmol/l

—

Injuries to the thorax

166

1041

1.60

7.64

1.1

1.29

7.04

nmol/l

2.19

200

Dental caries, including avohilmo

279

980

1.46

7.53

1.1

6.26

7.41

nmol/l

0.17

194

Irregular menses

195

999

1.55

7.51

1.1

3.07

4.62

nmol/l

0.21

184

Other cataract

156

726

1.63

7.47

1.0

1.1

3.97

7.56

nmol/l

0.61

141

Bacterial infection, other or unspecified

189

1061

1.55

7.47

1.1

3.68

7.45

nmol/l

1.00

208

Obesity due to excess calories

187

1213

1.55

7.47

1.0

1.1

3.17

6.50

nmol/l

0.76

235

Graves ophthalmopathy, strict

3.80

7.39

1.1

1.13

1.16

nmol/l

—

Disorders of vitreous body

180

1120

1.56

7.38

1.1

14.21

4.74

nmol/l

0.56

222

Internal derangement of knee

133

793

1.67

7.37

1.1

1.13

7.04

nmol/l

1.82

168

Osteoporosis

488

1.84

7.37

1.1

4.79

7.87

nmol/l

0.27

104

Localized swelling, mass and lump of skin and subcutaneous tissue

119

693

1.72

7.34

1.1

3.50

8.88

nmol/l

1.12

132

Genitourinary diseases

213

697

1.53

7.31

1.1

5.20

4.73

nmol/l

0.10

129

Viral and other specified intestinal infections

109

597

1.77

7.30

1.1

2.04

8.07

nmol/l

1.14

116

Superficial injury of head

490

1.86

7.29

1.1

2.39

10.53

nmol/l

1.43

Hernia of abdominal wall, postoperative

325

2.07

7.26

1.1

0.17

6.46

nmol/l

2.73

Unspecified urinary incontinence

173

2.50

7.24

1.0

1.1

7.81

15.00

nmol/l

0.29

Major coronary heart disease event

303

1295

1.41

7.19

1.1

5.64

5.95

nmol/l

0.04

259

Graves ophthalmopathy

3.60

7.18

1.1

1.13

0.89

nmol/l

—

Hyperkinetic disorders

249

2.21

7.15

1.1

0.15

4.20

nmol/l

—

Caries of dentine, including avohilmo

294

1053

1.43

7.14

1.1

5.90

6.99

nmol/l

0.17

209

Other disorders of adrenal gland

106

2.96

7.13

1.1

0.71

1.29

nmol/l

—

Falls/tendency to fall

419

1562

1.34

7.08

1.1

3.46

6.03

nmol/l

0.94

309

Other and unspecified injuries of head

140

2.66

7.05

1.0

1.1

1.19

5.56

nmol/l

—

Gingivitis and periodontal diseases

390

1486

1.36

7.00

1.1

3.55

6.20

nmol/l

0.87

277

Congenital malformations, deformations and chromosomal abnormalities

228

1487

1.46

6.98

1.1

4.24

5.36

nmol/l

0.24

288

Benign neoplasm of other and ill-defined parts of digestive system

392

1.95

6.97

1.1

7.20

10.37

nmol/l

0.20

Disorders of vitreous body and globe

183

1152

1.53

6.96

1.1

14.21

4.61

nmol/l

0.57

229

Speech therapy

107

615

1.75

6.95

1.1

2.22

8.81

nmol/l

1.44

124

Other spirochaetal diseases

120

712

1.69

6.95

1.1

3.91

7.75

nmol/l

0.58

137

Other symptoms and signs involving the urinary system

183

2.42

6.91

1.1

0.52

6.45

nmol/l

—

Tinnitus

543

1.79

6.90

1.2

1.1

1.21

10.13

nmol/l

1.94

107

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

118

699

1.69

6.87

1.1

4.73

6.36

nmol/l

0.12

133

Other spirochaetal diseases

121

723

1.68

6.83

1.1

3.91

7.75

nmol/l

0.58

137

Disorders of speech understanding and production

3.26

6.74

1.2

1.1

5.46

1.91

nmol/l

—

Diseases of salivary glands

126

764

1.65

6.73

1.1

1.19

7.72

nmol/l

1.96

155

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

211

1437

1.47

6.68

1.1

4.07

6.44

nmol/l

0.33

290

Atopic dermatitis

223

1254

1.46

6.65

1.1

2.45

6.59

nmol/l

1.21

233

Fissure and fistula of anal and rectal regions

513

1.80

6.64

1.0

1.1

0.25

6.31

nmol/l

4.75

102

Vasomotor and allergic rhinitis

139

852

1.60

6.58

1.1

3.26

7.71

nmol/l

0.91

167

Impingement syndrome of shoulder

464

1.84

6.58

1.0

1.1

1.68

9.15

nmol/l

1.48

103

Procreative management

127

643

1.65

6.57

1.1

0.52

6.86

nmol/l

1.45

125

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

366

1774

1.34

6.54

1.1

5.44

5.17

nmol/l

0.04

350

Adrenocortical insufficiency

3.10

6.48

1.1

0.71

1.56

nmol/l

—

Disorders of sclera, cornea, iris and ciliary body

202

1375

1.47

6.48

1.1

5.03

5.67

nmol/l

0.08

280

Implicit fungal Sepsis

3.16

6.45

1.0

1.1

0.73

5.46

nmol/l

—

Spirochaetal infections, other/unspecified

118

712

1.66

6.45

1.1

3.91

7.77

nmol/l

0.58

134

Disturbance of activity and attention

235

2.18

6.44

1.2

1.1

0.15

4.26

nmol/l

—

Lyme disease

117

705

1.67

6.43

1.1

3.91

7.83

nmol/l

0.58

133

Other viral diseases, not elsewhere classified

104

604

1.72

6.41

1.1

0.32

7.33

nmol/l

1.66

119

Senile cataract

212

881

1.48

6.40

1.1

9.39

6.53

nmol/l

0.29

170

KRA_PSY_EATING, excluding more controls

135

2.59

6.38

1.1

0.08

7.60

nmol/l

—

Unspecified haematuria

142

741

1.59

6.36

1.0

1.1

3.52

8.10

nmol/l

1.12

164

Polyarthrosis

355

1.92

6.35

1.1

1.0

7.25

9.79

nmol/l

0.15

All kidney diseases

368

1889

1.33

6.27

1.1

2.08

5.89

nmol/l

2.35

353

Other necrotizing vasculopathies (FG)

103

2.84

6.26

1.1

0.16

19.15

nmol/l

—

Benign neoplasm: Colon

189

1220

1.48

6.25

1.1

2.21

7.17

nmol/l

2.18

233

Phobic anxiety disorders

243

2.15

6.24

1.1

1.37

4.17

nmol/l

—

Other specified/unspecified soft tissue disorders

3.07

6.20

1.1

0.55

3.35

nmol/l

—

Dermatographic urticaria

162

2.43

6.19

1.1

0.14

5.85

nmol/l

—

Candidiasis

111

667

1.67

6.18

1.1

6.12

7.31

nmol/l

0.09

127

Other specified/unspecified dorsopathies

3.54

6.17

1.1

1.37

5.48

nmol/l

—

Encephalitis

3.24

6.17

1.1

0.09

1.67

nmol/l

—

Disorders of calcium metabolism

110

2.75

6.11

1.1

10.14

6.73

nmol/l

—

Fungal Sepsis

3.04

6.08

1.0

1.1

0.73

5.10

nmol/l

—

Cholecystectomy

258

1599

1.39

6.06

1.1

4.96

5.80

nmol/l

0.14

292

Abnormal findings on diagnostic imaging of lung

166

1056

1.51

6.03

1.1

3.60

6.74

nmol/l

0.85

217

Other menopausal disorders

107

351

1.72

6.03

1.0

1.1

0.16

3.50

nmol/l

1.49

Other specified/unspecified arthritis

544

1.73

6.02

1.1

0.32

9.36

nmol/l

2.21

116

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

385

1.83

5.97

1.1

0.14

4.48

nmol/l

1.37

Diseases of the digestive system

158

1036

1.52

5.97

1.1

3.88

6.91

nmol/l

0.72

212

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

156

637

1.55

5.96

1.1

2.93

7.75

nmol/l

0.80

119

Carbimazole or st.post thyroidectomy, condition for graves disease

509

1.76

5.95

1.0

1.1

10.49

7.27

nmol/l

0.17

108

Mycoses

102

606

1.69

5.95

1.1

6.32

9.33

nmol/l

0.29

117

Polycystic ovarian syndrome, consortium definition

271

1158

1.39

5.87

1.1

5.76

4.89

nmol/l

0.10

218

Nutritional anaemias

173

1123

1.49

5.87

1.1

2.05

7.14

nmol/l

2.03

226

Other and unspecified disorders of vitreous body

148

952

1.54

5.87

1.1

16.52

4.45

nmol/l

0.63

195

Zoster [herpes zoster]

174

1156

1.48

5.86

1.1

14.70

4.95

nmol/l

0.43

240

Other disorders of the musculoskeletal system and connective tissue

318

1.96

5.85

1.1

2.69

10.55

nmol/l

0.87

Heart failure, not strict

262

1283

1.39

5.83

1.0

1.1

6.15

5.84

nmol/l

0.04

251

Other and unspecified drugs and medicaments

192

2.25

5.82

1.2

1.1

0.42

6.24

nmol/l

—

Diabetic neuropathy

172

2.33

5.82

1.1

1.87

5.27

nmol/l

0.88

Other arthritis (FG)

106

640

1.66

5.82

1.1

0.38

7.15

nmol/l

1.94

132

Injuries to the hip and thigh

164

990

1.50

5.81

1.1

3.24

6.83

nmol/l

0.99

210

Bleeding

289

1509

1.36

5.80

1.1

3.56

5.61

nmol/l

0.52

307

Sensorineural hearing loss

259

1268

1.39

5.76

1.1

2.06

6.80

nmol/l

2.23

255

MS-disease / Multiple Sclerosis

174

2.32

5.76

1.0

1.1

4.38

5.85

nmol/l

—

Other encephalitis

3.28

5.74

1.1

0.09

1.27

nmol/l

—

Noninfective enteritis and colitis

169

1138

1.49

5.74

1.1

2.95

5.85

nmol/l

0.60

228

Other viral diseases

139

892

1.55

5.74

1.1

0.54

6.90

nmol/l

2.34

173

Other diseases of lip and oral mucosa

146

955

1.53

5.74

1.1

0.90

6.57

nmol/l

2.50

201

Persons encountering health services for specific procedures, not carried out

168

2.34

5.74

1.1

0.82

5.55

nmol/l

—

Statin medication

254

1022

1.40

5.72

1.1

5.13

4.50

nmol/l

0.08

206

Adenomyosis (Endometriosis of uterus)

259

2.06

5.72

1.1

3.76

4.53

nmol/l

—

Substance abuse, excluding more controls

178

1030

1.48

5.72

1.1

0.72

7.48

nmol/l

3.58

219

Graves disease, strict definition

253

2.07

5.69

1.1

5.30

5.79

nmol/l

—

Spontaneous rupture of synovium and tendon

144

2.44

5.69

1.1

1.08

16.84

nmol/l

—

Other diseases of anus and rectum

103

621

1.66

5.65

1.1

3.43

5.74

nmol/l

0.52

127

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

141

915

1.54

5.63

1.1

2.08

7.05

nmol/l

1.29

181

Congenital malformations and deformations of the musculoskeletal system

227

2.11

5.57

1.2

1.1

0.96

4.61

nmol/l

—

Ovarian cyst

128

462

1.60

5.56

1.1

3.80

4.02

nmol/l

0.02

Viral infections characterized by skin and mucous membrane lesions

153

1018

1.51

5.54

1.1

0.88

6.30

nmol/l

2.49

211

Other and unspecified urticaria

454

1.77

5.52

1.1

0.90

8.49

nmol/l

1.29

Speech and linguistic disorders

158

2.32

5.48

1.2

1.1

4.12

3.42

nmol/l

0.06

Other mental disorders due to brain damage and dysfunction and to physical disease

230

2.10

5.48

1.0

1.1

0.92

7.11

nmol/l

—

Other specified and unspecified personality disorders

204

2.17

5.46

1.1

0.46

5.58

nmol/l

1.25

Iron deficiency anaemia

149

976

1.51

5.44

1.1

1.03

6.89

nmol/l

2.48

194

All influenza

538

1.70

5.43

1.1

3.51

9.42

nmol/l

0.84

108

Hernia

338

1719

1.32

5.43

1.1

3.59

5.55

nmol/l

0.61

326

Injuries to the abdomen, lower back, lumbar spine and pelvis

137

886

1.53

5.41

1.1

1.65

7.16

nmol/l

1.85

188

Chronic gastritis

554

1.68

5.41

1.1

9.18

6.25

nmol/l

0.20

118

Raynaud syndrome

205

2.16

5.40

1.1

0.09

7.88

nmol/l

—

Herpesviral [herpes simplex] infections

578

1.67

5.37

1.1

0.94

8.05

nmol/l

1.64

120

Myocarditis

3.03

5.37

1.0

1.1

0.40

3.77

nmol/l

—

Other complications of surgical and medical care, not elsewhere classified

199

2.17

5.37

1.0

1.1

3.61

6.92

nmol/l

—

Unspecified/other endometriosis

174

2.25

5.31

1.1

10.65

3.66

nmol/l

—

Artrosis, including avohilmo

307

1256

1.34

5.29

1.1

12.31

4.02

nmol/l

0.72

244

Ischaemic heart disease, wide definition

267

1215

1.36

5.27

1.1

6.91

5.23

nmol/l

0.23

253

Spondylopathies (FG)

268

1.99

5.24

1.2

1.1

0.09

11.90

nmol/l

—

Viral and other specified intestinal infections

422

1.76

5.21

1.1

1.75

6.19

nmol/l

1.25

Fracture of skull and facial bones

448

1.75

5.19

1.1

1.78

10.47

nmol/l

1.53

Conductive and sensorineural hearing loss

268

1338

1.35

5.14

1.1

2.28

6.86

nmol/l

2.16

274

Asthma mixed form (mode), excluding more controls

3.02

5.10

1.1

1.2

1.12

7.33

nmol/l

—

Dermatopolymyositis (FG)

5.77

5.09

1.1

0.11

0.33

nmol/l

—

Other peripheral vertigo

184

2.19

5.09

1.1

0.84

5.17

nmol/l

—

Injuries to the shoulder and upper arm

294

1789

1.33

5.05

1.1

4.03

5.36

nmol/l

0.32

358

Congenital malformations and deformations of the musculoskeletal system

177

2.20

5.05

1.1

1.23

3.13

nmol/l

—

Adverse effects, not elsewhere classified

467

1.72

5.05

1.1

0.84

8.42

nmol/l

1.29

Aneurysms, operations, SAH

300

1.91

5.04

1.0

1.1

3.64

11.96

nmol/l

—

Inflammatory diseases of prostate (prostatitis)

218

2.07

5.02

1.2

1.1

0.94

6.64

nmol/l

—

Acute laryngitis and tracheitis

221

2.05

5.00

1.1

5.74

4.74

nmol/l

0.07

Other specified/unspecified inflammatory spondylopathies

2.82

4.98

1.1

0.09

5.04

nmol/l

—

Other symptoms and signs involving the circulatory and respiratory systems

111

2.54

4.95

1.0

1.1

18.68

6.82

nmol/l

—

Chronic diseases of tonsils and adenoids

281

1331

1.34

4.92

1.1

4.30

6.36

nmol/l

0.41

255

Unknown and unspecified causes of morbidity

100

2.61

4.89

1.0

1.1

9.37

13.86

nmol/l

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

127

524

1.54

4.86

1.1

6.85

1.99

nmol/l

0.40

Arthropathies in other diseases classified elsewhere

3.01

4.84

1.1

0.28

1.24

nmol/l

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

458

1.71

4.83

1.1

2.50

9.86

nmol/l

1.21

Other bursopathies

235

2.01

4.83

1.0

1.1

3.87

14.22

nmol/l

—

Other noninfective gastroenteritis and colitis

541

1.65

4.83

1.1

1.18

8.89

nmol/l

1.71

112

Coxarthrosis, primary

194

1175

1.40

4.78

1.0

1.1

5.05

6.36

nmol/l

0.26

234

Cholelithiasis, broad definition with cholecystitis

309

1590

1.31

4.77

1.1

4.41

5.56

nmol/l

0.23

290

Budesonide

292

1.89

4.76

1.1

2.31

11.47

nmol/l

0.65

Asthma mixed form (mode)

2.89

4.76

1.1

1.2

1.12

13.06

nmol/l

—

Hyperparathyroidism

360

1.79

4.74

1.0

1.1

1.37

9.73

nmol/l

—

Other obstetric conditions, not elsewhere classified

129

539

1.53

4.71

1.1

6.51

1.95

nmol/l

0.39

Flat foot [pes planus] (acquired)

177

2.16

4.71

1.1

0.16

12.33

nmol/l

—

Chondrocostal junction syndrome [Tietze]

2.73

4.69

1.1

1.45

0.36

nmol/l

—

Chondropathies

344

1.81

4.68

1.0

1.1

0.77

6.03

nmol/l

1.87

Sequelae of external causes of morbidity and mortality

577

1.62

4.68

1.1

3.80

9.13

nmol/l

0.92

115

Other acute lower respiratory infections

178

1205

1.41

4.65

1.1

7.83

5.61

nmol/l

0.28

236

Hypokalaemia

225

2.01

4.64

1.1

10.40

14.59

nmol/l

—

Artificial joint operation, meniscal resection

314

1568

1.30

4.63

1.1

6.53

5.52

nmol/l

0.16

314

Fitting and adjustment of other devices

116

684

1.53

4.61

1.0

1.1

9.01

6.04

nmol/l

0.24

152

Other noninflammatory disorders of uterus, except cervix

287

1.74

4.61

1.1

3.90

4.11

nmol/l

0.02

Other and unspecified iron deficiency

115

752

1.53

4.61

1.1

1.30

8.12

nmol/l

2.15

152

Specific development disorders of speech and language

105

2.49

4.59

1.2

1.1

4.92

1.45

nmol/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

122

2.40

4.57

1.0

1.1

1.79

2.74

nmol/l

—

Acute bronchitis

137

913

1.47

4.56

1.0

1.1

8.36

6.42

nmol/l

0.21

184

Coronary atherosclerosis

212

975

1.38

4.56

1.1

10.94

5.89

nmol/l

0.65

199

Other medical care

147

910

1.45

4.53

1.0

1.1

25.85

5.70

nmol/l

0.40

202

Other/unspecified disorders of vestibular function

2.74

4.52

1.0

1.1

1.38

2.47

nmol/l

—

Schizophrenia or delusion, excluding more controls

561

1.61

4.51

1.1

1.61

8.46

nmol/l

1.44

114

Sequelae of injuries, of poisoning and of other consequences of external causes

544

1.62

4.51

1.1

0.60

9.10

nmol/l

1.85

106

Renal tubulo-interstitial diseases

305

1752

1.30

4.51

1.1

1.62

6.19

nmol/l

3.10

345

Other hearing loss

540

1.62

4.49

1.1

4.31

9.76

nmol/l

0.88

112

Injuries to the ankle and foot

255

1713

1.32

4.48

1.1

1.60

5.27

nmol/l

1.88

325

Disorders of gallbladder, biliary tract and pancreas

351

1734

1.28

4.48

1.1

5.16

5.21

nmol/l

0.01

323

Other hammer toe(s) (acquired)

294

1.83

4.47

1.1

1.0

7.16

11.08

nmol/l

0.19

Female genital prolapse

100

353

1.60

4.45

1.1

19.55

3.79

nmol/l

0.50

Disorders of parathyroid gland

426

1.70

4.45

1.1

1.21

9.55

nmol/l

1.38

Hypo-osmolality and hyponatraemia

326

1.81

4.45

1.1

1.25

11.14

nmol/l

—

Ménière disease

175

2.13

4.43

1.1

0.31

6.58

nmol/l

—

Benign neoplasm of other and unspecified endocrine glands

286

1.86

4.40

1.1

7.08

11.44

nmol/l

0.24

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

104

665

1.55

4.40

1.1

1.40

4.81

nmol/l

1.27

133

Early lumbar disc prolapse, operated

163

2.16

4.36

1.1

0.10

3.38

nmol/l

—

Poisoning by drugs, medicaments and biological substances

565

1.60

4.35

1.1

0.46

4.48

nmol/l

2.22

104

Cholelithiasis

294

1562

1.30

4.34

1.1

4.59

5.52

nmol/l

0.17

285

Suicide or other Intentional self-harm

582

1.59

4.31

1.1

0.50

7.31

nmol/l

1.49

113

Congenital malformations of the circulatory system

300

1.82

4.30

1.1

7.35

6.11

nmol/l

—

Excessive attrition of teeth

203

1497

1.36

4.30

1.1

0.63

5.72

nmol/l

3.38

298

Diseases of male genital organs

158

552

1.45

4.30

1.1

4.53

5.02

nmol/l

0.10

112

Endometriosis ASRM stages 1,2

430

1.68

4.25

1.1

0.45

7.54

nmol/l

—

Colonic or urogenital fistula

624

1.56

4.24

1.0

1.1

0.25

8.96

nmol/l

2.40

123

Other disorders of conjunctiva

276

1.85

4.21

1.1

1.59

12.33

nmol/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

101

657

1.54

4.20

1.1

0.15

8.35

nmol/l

2.23

125

False labour

115

472

1.52

4.20

1.1

1.33

3.64

nmol/l

0.54

Benign neoplasm of brain and other parts of central nervous system

140

2.23

4.18

1.2

1.1

0.09

3.14

nmol/l

—

Attention to artificial openings

2.68

4.16

1.1

1.2

—

9.77

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

101

660

1.53

4.12

1.0

1.1

1.06

8.66

nmol/l

2.12

134

Periodontitis

342

1809

1.27

4.12

1.1

3.11

5.49

nmol/l

1.00

346

Superficial injury of abdomen, lower back and pelvis

322

1.78

4.10

1.1

3.03

7.94

nmol/l

—

Other diseases of liver

404

1.69

4.10

1.1

5.24

10.66

nmol/l

0.41

Adhesive capsulitis of shoulder

315

1.78

4.09

1.0

1.1

1.61

12.60

nmol/l

—

Other necrotizing vasculopathies

142

2.20

4.05

1.1

0.16

5.80

nmol/l

—

Presence of other functional implants

190

965

1.37

4.02

1.0

1.1

5.71

6.66

nmol/l

0.15

200

Chronic periodontitis, including avohilmo

340

1808

1.26

4.01

1.1

3.15

5.47

nmol/l

0.97

347

Amenorrhoea

111

2.35

3.99

1.1

0.11

4.24

nmol/l

—

Injuries to the wrist and hand

356

1972

1.25

3.95

1.1

1.07

5.78

nmol/l

3.93

370

Superficial injury of lower leg

564

1.56

3.94

1.1

1.68

8.12

nmol/l

1.27

114

Angina pectoris

181

879

1.37

3.93

1.1

7.10

6.40

nmol/l

0.06

180

Visual field defects

112

2.33

3.91

1.1

0.12

8.68

nmol/l

—

Injuries to the knee and lower leg

424

1913

1.23

3.91

1.1

2.87

5.55

nmol/l

1.30

368

Systemic lupus erythematosus

2.66

3.90

1.1

0.36

0.97

nmol/l

—

Early onset COPD, excluding more controls

342

1.73

3.89

1.0

1.1

8.63

10.52

nmol/l

0.10

Other gastritis (incl. Duodenitis)

464

1.62

3.89

1.1

0.68

8.28

nmol/l

1.60

103

Other bacterial intestinal infections

488

1.60

3.87

1.0

1.1

1.00

10.30

nmol/l

1.76

Fibroblastic disorders

442

1.63

3.85

1.0

1.1

0.62

10.39

nmol/l

2.08

Poisoning by medicine

512

1.59

3.85

1.1

0.46

4.79

nmol/l

2.24

Endometriosis of ovary

350

1.71

3.83

1.1

7.99

3.52

nmol/l

0.31

Pregnancy examination and test

223

1.73

3.80

1.1

1.10

5.50

nmol/l

—

Abnormal findings on diagnostic imaging of other body structures

294

1.78

3.77

1.0

1.1

7.45

10.53

nmol/l

—

Presbyopia

127

2.22

3.76

1.0

1.1

0.98

2.65

nmol/l

—

Reactive arthropathies, FINNGEN

127

2.22

3.76

1.1

0.17

2.02

nmol/l

—

Reactive arthropathies

160

2.07

3.76

1.2

1.1

0.17

15.64

nmol/l

—

Superficial injury of wrist and hand

453

1.62

3.76

1.0

1.1

0.12

9.62

nmol/l

1.73

Other/unspecified soft tissue disorders related to use, overuse and pressure

2.94

3.74

1.2

1.1

0.12

1.51

nmol/l

—

Recurrent aphthous stomatitis , including avohilmo

310

1.75

3.72

1.1

1.21

12.44

nmol/l

1.38

Valvular heart disease excluding rheumatic fever

149

770

1.40

3.68

1.1

10.03

8.06

nmol/l

0.14

144

Hyperplasia of prostate

105

397

1.50

3.62

1.1

7.33

6.30

nmol/l

0.17

Unspecified fall

162

1171

1.36

3.61

1.0

1.1

3.43

5.94

nmol/l

0.60

235

Atopic dermatitis, strict definition with reimbursement

102

665

1.48

3.60

1.1

3.98

6.80

nmol/l

0.29

134

Other bacterial intestinal infections

366

1.67

3.59

1.0

1.1

1.19

12.07

nmol/l

1.60

Type of accident

658

1.49

3.58

1.1

8.07

8.06

nmol/l

0.00

135

Necrosis of pulp, including avohilmo

204

1549

1.32

3.56

1.1

1.76

5.67

nmol/l

1.90

301

Striking against or struck by other objects

111

765

1.45

3.54

1.1

1.29

7.53

nmol/l

1.86

149

Brain meningioma, including Hilmo

105

2.30

3.52

1.0

1.1

2.09

7.19

nmol/l

—

Non-rheumatic valve diseases

147

764

1.39

3.52

1.1

10.03

7.66

nmol/l

0.17

142

Familial hypercholesterolemia

271

1.78

3.52

1.0

1.1

4.47

12.15

nmol/l

0.77

Herpesviral [herpes simplex] infections

272

1.77

3.48

1.0

1.1

1.51

6.10

nmol/l

—

Other noninflammatory disorders of vulva and perineum

172

1.98

3.48

1.1

0.15

4.00

nmol/l

—

Keratitis

120

844

1.42

3.46

1.1

2.72

6.48

nmol/l

0.98

171

Other and unspecified tonsillitis

112

651

1.45

3.45

1.1

6.28

3.47

nmol/l

0.23

127

Unspecified mental disorder

137

989

1.39

3.40

1.1

0.60

6.40

nmol/l

2.59

199

Benign neoplasm: Rectum, anus and anal canal

434

1.59

3.40

1.1

0.23

10.11

nmol/l

2.03

Open wound of head

168

1208

1.34

3.38

1.1

5.07

6.59

nmol/l

0.19

245

Hallux valgus (acquired)

106

522

1.46

3.36

1.1

1.31

9.36

nmol/l

1.65

109

Disorders of skin appendages

166

1238

1.34

3.35

1.0

1.1

1.78

6.43

nmol/l

1.98

259

Covid-19 suspected case

507

1.54

3.34

1.1

0.95

5.41

nmol/l

2.06

102

Chalazion

203

1.88

3.33

1.1

10.66

2.80

nmol/l

—

Memory loss

175

1.95

3.33

1.1

2.36

8.40

nmol/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

114

2.20

3.33

1.1

3.69

11.92

nmol/l

—

Rheumatoid arthritis

591

1.47

3.32

1.1

2.55

9.01

nmol/l

1.16

120

SLE, strict definition

2.43

3.31

1.1

0.36

0.83

nmol/l

—

SLE, ICD10

2.43

3.31

1.1

0.36

0.83

nmol/l

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

162

1.98

3.28

1.1

0.21

3.25

nmol/l

—

Caries of enamel

315

1837

1.24

3.27

1.1

1.32

5.75

nmol/l

3.14

344

Dermatophytosis

201

1550

1.30

3.21

1.1

6.56

5.36

nmol/l

0.17

298

Fall on same level involving ice and snow

190

1456

1.31

3.21

1.1

2.34

5.80

nmol/l

1.36

289

Hypermetropia

116

2.16

3.21

1.1

0.40

4.46

nmol/l

—

conjunctival haemorrhage

150

2.01

3.20

1.2

1.1

0.25

3.63

nmol/l

—

Other skin changes

364

1.63

3.17

1.0

1.1

6.27

12.76

nmol/l

—

Disorders of choroid and retina

261

1474

1.26

3.16

1.1

4.45

6.31

nmol/l

0.35

297

Other abnormal uterine and vaginal bleeding

331

1.56

3.12

1.1

1.30

3.87

nmol/l

0.90

Other condition

320

1.66

3.10

1.1

17.46

6.51

nmol/l

—

Other female pelvic inflammatory diseases

391

1.59

3.06

1.0

1.1

1.48

10.44

nmol/l

—

Exposure to other and unspecified animate mechanical forces

2.52

3.05

1.2

1.1

1.52

0.35

nmol/l

—

Erysipelas

176

1188

1.31

3.04

1.0

1.1

2.25

7.04

nmol/l

2.01

235

Sequelae with surgical and medical care as external cause

440

1.55

3.01

1.1

3.35

11.05

nmol/l

1.09

Gonarthrosis,primary

294

1465

1.24

3.00

1.1

5.53

5.82

nmol/l

0.04

286

Persons encountering health services in circumstances related to reproduction

193

1002

1.30

2.99

1.1

0.79

5.82

nmol/l

1.77

183

Persons with potential health hazards related to communicable diseases

130

947

1.36

2.95

1.1

7.01

5.00

nmol/l

0.13

186

Childhood asthma (age<16)

165

1.82

2.95

1.1

0.66

5.82

nmol/l

—

Childhood asthma (age<16), excluding more controls

165

1.82

2.94

1.1

0.66

5.82

nmol/l

—

Special screening examination for other diseases and disorders

148

1.96

2.93

1.1

19.54

15.23

nmol/l

—

Malignant neoplasm of digestive organs

715

0.64

2.93

1.1

2.58

6.12

nmol/l

0.79

147

Supplementary factors related to causes of morbidity and mortality classified elsewhere

101

713

1.42

2.92

1.1

7.79

7.61

nmol/l

0.01

150

Algoneurodystrophy

2.39

2.90

1.0

1.1

0.08

0.29

nmol/l

—

Benign neoplasm: Rectum

389

1.57

2.89

1.2

1.1

0.25

10.73

nmol/l

—

Other and unspecified mood [affective] disorders

142

1.98

2.89

1.1

0.11

6.53

nmol/l

—

Glucosamine medication

146

872

1.34

2.87

1.1

7.56

6.87

nmol/l

0.07

177

Excessive vomiting in pregnancy

185

1.85

2.87

1.0

1.1

0.09

2.49

nmol/l

—

Acute pharyngitis

279

1.67

2.86

1.1

0.30

5.67

nmol/l

—

Gout

419

1.51

2.85

1.1

3.43

8.26

nmol/l

0.62

Aplastic and other anaemias

138

959

1.34

2.85

1.1

2.68

7.46

nmol/l

1.55

203

Diseases of arteries, arterioles and capillaries

208

1207

1.27

2.84

1.1

2.27

7.11

nmol/l

2.12

248

Misadventures to patients during surgical and medical care

313

1.63

2.84

1.0

1.1

1.29

12.67

nmol/l

—

Organic, including symptomatic, mental disorders

151

809

1.33

2.82

1.0

1.1

2.87

8.18

nmol/l

1.39

172

Venous thromboembolism

167

1239

1.30

2.81

1.1

4.52

6.53

nmol/l

0.35

250

Paralytic ileus and intestinal obstruction

520

1.48

2.81

1.1

0.57

6.22

nmol/l

4.32

109

Abscess of anal and rectal regions

172

1.87

2.81

1.1

1.02

5.79

nmol/l

—

Malignant neoplasm of heart, mediastinum and pleura

3.63

2.80

1.1

2.05

6.71

nmol/l

—

Other and unspecified anaemias

128

904

1.35

2.77

1.1

2.39

7.86

nmol/l

1.76

189

Other disorders of bladder

217

1.76

2.75

1.1

2.03

13.64

nmol/l

0.99

Allergic contact dermatitis

308

1.63

2.75

1.1

1.25

12.45

nmol/l

—

Other diseases of oesophagus

195

1.80

2.75

1.0

1.1

20.77

2.97

nmol/l

—

Candidiasis

316

1.62

2.74

1.1

2.79

11.93

nmol/l

0.91

Type 2 diabetes, wide definition

268

1391

1.23

2.73

1.0

1.1

2.89

6.00

nmol/l

0.93

281

Systemic lupus erythematosus, unspecified

2.38

2.73

1.1

0.42

0.97

nmol/l

—

Sacrococcygeal disorders, not elsewhere classified

2.73

2.72

1.1

0.84

1.67

nmol/l

—

Pulmonary heart disease

632

1.43

2.70

1.1

5.75

8.39

nmol/l

0.27

137

Unstable angina pectoris

109

621

1.39

2.70

1.1

1.06

7.40

nmol/l

1.69

131

Inflammatory diseases of the central nervous system

189

1.81

2.70

1.1

0.11

4.06

nmol/l

—

Achilles tendinitis

189

1.80

2.70

1.1

0.08

15.14

nmol/l

—

Psychotic depression

2.18

2.67

1.1

0.34

11.61

nmol/l

—

Atopic dermatitis, strict definition

695

1.40

2.65

1.1

3.98

6.44

nmol/l

0.25

137

Pulmonary embolism

635

1.42

2.64

1.1

5.75

8.32

nmol/l

0.27

138

Erysipelas

233

1432

1.24

2.63

1.1

4.39

6.13

nmol/l

0.31

279

Unspecified event, undetermined intent

2.48

2.63

1.1

0.73

1.37

nmol/l

—

Other anaemias

128

910

1.34

2.63

1.1

2.39

7.78

nmol/l

1.75

191

Noninfectious colitis NAS

289

1.63

2.62

1.1

2.09

7.60

nmol/l

—

Mental disorders, not otherwise specified

191

1.79

2.62

1.0

1.1

0.28

6.30

nmol/l

—

Fracture of shoulder and upper arm

110

804

1.37

2.62

1.1

2.96

7.72

nmol/l

1.08

171

Abnormal findings on examination of blood, without diagnosis

145

1014

1.31

2.61

1.1

5.14

7.28

nmol/l

0.30

203

Eating disorders

243

1.69

2.61

1.1

0.09

4.69

nmol/l

—

Malignant neoplasm of oesophagus, including Hilmo

0.00

2.61

0.0

1.1

—

8.12

—

Reimbursement for rheumatic diseases

185

1452

1.27

2.60

1.1

2.98

5.74

nmol/l

0.61

294

Recurrent dislocation and subluxation of joint

134

1.95

2.59

1.1

0.21

3.82

nmol/l

—

Seronegative rheumatoid arthritis

214

1.73

2.58

1.1

2.34

11.27

nmol/l

—

Maternal care for other conditions predominantly related to pregnancy

520

1.46

2.58

1.1

0.10

2.99

nmol/l

1.07

Kela-code for severe mental illness

117

867

1.35

2.58

1.1

0.68

6.67

nmol/l

2.26

176

Rash and other nonspecific skin eruption

192

1.78

2.58

1.1

4.10

5.07

nmol/l

0.10

Spondyloarthritis

377

1.54

2.57

1.2

1.1

0.09

6.57

nmol/l

—

Abrasion of teeth

112

825

1.36

2.57

1.1

5.22

6.92

nmol/l

0.14

169

Divergent concomitant strabismus

142

1.91

2.55

1.1

—

7.65

nmol/l

—

Allergic rhinitis

103

741

1.38

2.54

1.1

1.69

6.50

nmol/l

1.07

144

Open wound of hip and thigh

2.24

2.54

1.1

1.2

5.59

1.01

nmol/l

—

All influenza (not pneumonia)

307

1.60

2.54

1.0

1.1

4.65

7.93

nmol/l

0.38

Transport accidents

146

961

1.31

2.54

1.1

1.20

7.82

nmol/l

2.34

180

Postmenopausal bleeding

292

1.46

2.51

1.1

4.39

2.83

nmol/l

0.16

L04AA Selective immunosuppressants

526

1.45

2.50

1.1

3.06

9.49

nmol/l

0.96

Disorders of breast

167

1186

1.28

2.48

1.1

1.34

5.63

nmol/l

1.46

220

Diseases of middle ear and mastoid

191

1241

1.26

2.47

1.1

4.61

5.58

nmol/l

0.14

238

Inflammatory bowel disease

102

747

1.37

2.44

1.0

1.1

5.63

6.96

nmol/l

0.10

152

Inflammatory disease of uterus

335

1.56

2.42

1.1

0.12

10.59

nmol/l

—

Diseases of liver

110

817

1.35

2.41

1.1

5.03

7.56

nmol/l

0.31

156

Hernia of abdominal wall

143

1103

1.30

2.41

1.1

0.90

6.79

nmol/l

2.91

216

Alcohol abuse, main dg, excluding more controls

257

1.64

2.41

1.1

1.17

8.54

nmol/l

—

Primary open-angle glaucoma

617

1.40

2.41

1.1

1.77

8.10

nmol/l

1.59

133

Adenocarcinoma and ductal carcinoma of pancreas

0.00

2.41

0.0

1.1

—

11.65

—

Vestibular neuronitis

189

1.75

2.41

1.0

1.1

0.09

5.84

nmol/l

—

Nummular dermatitis

167

1.80

2.40

1.1

2.77

8.16

nmol/l

—

Other retinal disorders

193

1200

1.25

2.39

1.1

3.32

6.56

nmol/l

0.79

252

Eating disorder

204

1.72

2.39

1.1

0.08

4.92

nmol/l

—

Other disorders of veins

132

1003

1.31

2.38

1.1

17.53

5.49

nmol/l

0.40

210

Social phobias

153

1.84

2.37

1.1

0.28

5.99

nmol/l

—

Other aneurysm

2.07

2.37

1.2

1.1

2.39

5.10

nmol/l

—

Trigger finger

274

1.61

2.36

1.1

0.08

12.69

nmol/l

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

3.06

2.36

1.1

2.05

6.51

nmol/l

—

Injuries to unspecified part of trunk, limb or body region

213

1.70

2.35

1.1

2.14

6.52

nmol/l

—

Bacterial pneumonia (organism specified)

134

932

1.31

2.33

1.1

4.22

7.08

nmol/l

0.50

190

Other or unspecified ileus, impaction or obstruction

346

1.53

2.33

1.1

0.68

5.77

nmol/l

—

Other inflammatory liver diseases

147

1.84

2.32

1.1

9.90

7.19

nmol/l

—

Acute tubulo-interstitial nephritis

199

1383

1.24

2.32

1.1

1.71

7.07

nmol/l

2.91

283

Dislocation, sprain and strain of joints and ligaments of knee

203

1512

1.24

2.31

1.1

3.66

5.36

nmol/l

0.42

305

Lesion of sciatic nerve

2.19

2.31

1.1

1.2

0.21

5.18

nmol/l

—

Additional codes for the location of defect, injury or illness

126

1.91

2.30

1.1

2.03

2.86

nmol/l

—

Coxarthrosis, primary, with hip surgery

137

989

1.30

2.30

1.1

6.55

7.00

nmol/l

0.06

198

Appendectomy

218

1700

1.23

2.29

1.1

3.23

5.45

nmol/l

0.71

336

Bacterial pneumonia, not elsewhere classified

118

785

1.33

2.29

1.1

3.67

7.42

nmol/l

0.62

150

Bacterial pneumoniae

123

825

1.32

2.27

1.1

4.37

6.95

nmol/l

0.39

161

Malignant melanoma of skin

223

1.66

2.27

1.2

1.1

3.20

9.34

nmol/l

—

Mental and behavioural disorders due to psychoactive substance use

186

1384

1.25

2.26

1.1

0.72

6.30

nmol/l

3.88

280

Secondary hypertension

119

1.91

2.22

1.1

0.75

19.32

nmol/l

—

Foreign body entering into or through eye or natural orifice

179

1.74

2.22

1.2

1.1

2.62

4.60

nmol/l

—

Benign neoplasm: Colon, unspecified

540

1.41

2.21

1.0

1.1

3.62

9.29

nmol/l

0.92

111

Contact with and exposure to communicable diseases

103

767

1.34

2.19

1.1

8.81

3.16

nmol/l

0.36

156

Primary open-angle glaucoma, strict

515

1.42

2.18

1.1

1.38

8.84

nmol/l

1.64

112

Other diseases of the digestive system

686

1.36

2.17

1.0

1.1

4.34

8.50

nmol/l

0.73

143

Other/unspecified synovitis and tenosynovitis

211

1.66

2.16

1.0

1.1

0.10

15.35

nmol/l

—

Other specified and unspecified disorders of eyelid

3.03

2.15

1.1

—

2.22

—

Acute and subacute iridocyclitis

427

1.46

2.14

1.0

1.1

17.81

9.06

nmol/l

—

Iridocyclitis

511

1.41

2.12

1.0

1.1

15.28

9.21

nmol/l

—

100

Malignant neoplasm of bronchus and lung, including Hilmo

366

0.57

2.11

1.1

2.54

7.72

nmol/l

—

Gonarthrosis, primary, with knee surgery

168

1069

1.25

2.11

1.1

4.59

6.12

nmol/l

0.28

211

Pollen allergy

423

1.45

2.11

1.1

0.09

3.08

nmol/l

1.65

Coeliac disease

275

1.57

2.10

1.2

1.1

3.51

7.01

nmol/l

—

Other viral diseases

671

1.35

2.10

1.1

0.81

7.25

nmol/l

1.58

127

Stomatitis and related lesions

454

1.43

2.09

1.1

0.93

10.65

nmol/l

1.71

Other maternal disorders predominantly related to pregnancy

189

958

1.24

2.08

1.1

3.29

5.14

nmol/l

0.26

175

Endometriosis ASRM stages 3,4

564

1.39

2.07

1.1

6.29

6.36

nmol/l

0.00

108

Collagenous colitis

207

1.65

2.04

1.1

0.73

6.28

nmol/l

1.37

Focal epilepsy

465

1.42

2.03

1.0

1.1

0.12

9.97

nmol/l

—

101

Anogenital herpesviral [herpes simplex] infection

246

1.59

2.03

1.1

2.66

4.83

nmol/l

—

Bacterial intestinal infections, IBD co-morbidities

391

1.46

2.03

1.0

1.1

0.44

11.77

nmol/l

2.00

Valvular operations

278

1.55

2.02

1.0

1.1

0.13

6.38

nmol/l

—

AV-block

306

1.49

2.02

1.0

1.1

5.20

12.42

nmol/l

0.67

Melanocytic naevi

704

1.34

2.01

1.1

1.25

7.69

nmol/l

1.78

142

DVT of lower extremities and pulmonary embolism

124

962

1.29

2.00

1.1

4.70

7.18

nmol/l

0.36

201

Corns and callosities

155

1.75

2.00

1.1

0.09

7.01

nmol/l

—

Malignant melanoma

303

1.52

1.99

1.2

1.0

3.88

7.93

nmol/l

0.93

Focal epilepsy, strict definition

426

1.43

1.98

1.0

1.1

0.12

10.64

nmol/l

—

Presbycusis

230

1.60

1.97

1.1

2.35

16.49

nmol/l

—

Substance abuse

178

1361

1.23

1.97

1.1

0.72

6.00

nmol/l

3.57

273

Open wound of wrist and hand

137

1060

1.26

1.95

1.1

1.38

6.45

nmol/l

2.04

204

Umbilical hernia

615

1.35

1.92

1.1

1.21

9.80

nmol/l

2.29

124

Other diseases of blood and blood-forming organs, wide

488

1.40

1.91

1.1

5.69

9.30

nmol/l

0.34

110

Focal epilepsy, mode (most common among epilepsy diagnosis)

397

1.44

1.89

1.1

0.13

10.83

nmol/l

—

Excessive earwax

162

1281

1.24

1.89

1.1

1.96

6.76

nmol/l

2.14

253

Cardiac murmurs and other cardiac sounds

156

1.71

1.89

1.0

1.1

0.09

12.38

nmol/l

—

Hallux rigidus

259

1.55

1.89

1.1

1.0

1.42

10.62

nmol/l

—

Tonsillectomy and adenotomy

190

1085

1.22

1.88

1.1

2.34

5.80

nmol/l

0.91

198

COPD (mode)

429

1.37

1.88

1.0

1.1

5.53

9.76

nmol/l

0.31

Pulmonary heart disease, diseases of pulmonary circulation

695

1.33

1.88

1.1

5.47

7.91

nmol/l

0.27

146

Malignant neoplasm of oesophagus

0.00

1.87

0.0

1.1

—

8.54

—

Non-follicular lymphoma

189

1.65

1.87

1.0

1.1

0.13

8.03

nmol/l

—

Special screening examination for neoplasms

2.09

1.86

1.0

1.1

11.96

9.09

nmol/l

—

Adenocarcinoma of pancreas

0.00

1.85

0.0

1.1

—

4.76

—

Macular pucker

317

1.49

1.85

1.1

4.13

11.90

nmol/l

—

Erosion of teeth , including avohilmo

586

1.35

1.83

1.1

3.09

7.55

nmol/l

0.74

114

Anterior Iridocyclitis

467

1.39

1.83

1.0

1.1

15.28

8.50

nmol/l

—

5-aminosalicylic acid

442

1.40

1.83

1.1

0.62

7.99

nmol/l

0.89

All chronic kidney diseases

158

1046

1.24

1.83

1.1

2.86

7.59

nmol/l

1.57

207

Acute renal failure

426

1.41

1.81

1.1

1.55

10.47

nmol/l

1.66

Glaucoma

164

1149

1.23

1.81

1.1

8.45

6.88

nmol/l

0.12

238

Non-Hodgkin lymphoma, all, including Hilmo

278

1.51

1.81

1.0

1.1

0.12

8.73

nmol/l

—

Lesion of lateral popliteal nerve

101

1.89

1.81

1.2

1.1

0.13

6.62

nmol/l

—

Event of undetermined intent

138

1.75

1.79

1.2

1.1

0.63

4.57

nmol/l

—

Periapical abscess

143

1152

1.24

1.79

1.1

4.80

6.61

nmol/l

0.28

223

Degeneration of macula and posterior pole

131

829

1.26

1.78

1.1

2.96

7.42

nmol/l

0.98

186

Primary_lymphoid and hematopoietic malignant neoplasms

504

1.37

1.77

1.0

1.1

0.11

10.15

nmol/l

—

108

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

151

1063

1.24

1.77

1.1

6.36

5.00

nmol/l

0.10

196

184

1340

1.21

1.76

1.1

1.95

6.12

nmol/l

1.77

268

Vitamin deficiency, wide

102

1.87

1.76

1.2

1.1

0.10

4.42

nmol/l

—

Vitamin deficiency

102

1.87

1.76

1.2

1.1

0.10

4.42

nmol/l

—

Overexertion and strenuous or repetitive movements

216

1.58

1.76

1.2

1.1

5.68

6.38

nmol/l

—

Bitten or struck by other mammals

272

1.51

1.76

1.0

1.1

0.67

7.00

nmol/l

1.58

L02BB Anti-androgens

153

0.39

1.75

1.0

1.1

—

10.46

—

Diabetic retinopathy, excluding more controls

275

1.39

1.72

1.1

1.0

0.15

4.91

nmol/l

—

Gastric ulcer

347

1.44

1.72

1.1

0.58

8.70

nmol/l

1.14

Viral haemorrhagic fevers, not elsewhere classified/unspecified

347

1.44

1.72

1.1

6.60

11.78

nmol/l

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

389

1.42

1.71

1.1

0.28

4.34

nmol/l

2.13

Dysplasia of cervi uteri

402

1.35

1.71

1.0

1.1

0.30

4.50

nmol/l

1.55

Infections of the skin and subcutaneous tissue

180

1480

1.21

1.69

1.1

0.42

6.08

nmol/l

4.19

302

Seropositive rheumatoid arthritis

498

1.36

1.69

1.1

2.95

8.88

nmol/l

0.84

100

Intestinal stricture

690

1.31

1.69

1.1

19.59

6.45

nmol/l

0.30

143

Conduction disorders

515

1.32

1.69

1.0

1.1

4.43

8.85

nmol/l

0.58

Benign neoplasm: Sigmoid colon

407

1.40

1.69

1.1

1.26

10.78

nmol/l

1.65

Injuries to the elbow and forearm

221

1643

1.18

1.67

1.0

1.1

10.19

4.80

nmol/l

0.28

323

Haemorrhage in early pregnancy

707

1.30

1.67

1.1

0.57

6.48

nmol/l

1.33

129

Hypertrophic scar

119

1.77

1.66

1.0

1.1

4.15

4.02

nmol/l

—

Other specified/unspecified bacterial intestinal infections

134

1.72

1.66

1.0

1.1

0.80

3.02

nmol/l

—

Presence of other devices

483

1.36

1.66

1.1

0.43

9.02

nmol/l

1.90

102

Other congenital malformations

284

1.48

1.65

1.2

1.1

0.89

6.95

nmol/l

1.62

Nonsuppurative otitis media

441

1.36

1.65

1.1

3.93

5.70

nmol/l

—

Protozoal diseases

1.99

1.65

1.0

1.2

—

2.02

—

Nonalcoholic fatty liver disease

228

1.54

1.64

1.0

1.1

0.10

4.96

nmol/l

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

301

1.46

1.64

1.0

1.1

0.17

11.85

nmol/l

—

Phlebitis and thrombophlebitis (not including DVT)

529

1.34

1.64

1.1

7.90

6.27

nmol/l

0.12

108

Optic neuritis

105

1.82

1.63

1.1

2.37

0.56

nmol/l

—

Uterine polyps

189

1.59

1.62

1.1

0.09

5.70

nmol/l

—

Sulfonylureas

587

0.72

1.62

1.0

1.1

2.91

8.97

nmol/l

—

135

Long labour

570

0.70

1.61

1.1

0.12

4.83

nmol/l

—

Renal failure

124

880

1.25

1.61

1.1

1.61

7.94

nmol/l

2.44

184

GI-bleeding

687

1.30

1.61

1.0

1.1

4.17

8.50

nmol/l

0.79

143

Abnormal serum enzyme levels

644

1.30

1.60

1.1

6.60

6.24

nmol/l

0.04

135

Pediculosis, acariasis and other infestations

378

1.40

1.60

1.1

0.52

5.95

nmol/l

2.10

Effects of foreign body entering through natural orifice

540

1.34

1.60

1.1

1.87

9.40

nmol/l

1.58

111

Liquid cancers, helper endpoint

113

784

1.26

1.59

1.1

3.55

5.99

nmol/l

0.43

156

Other disorders of the genitourinary system

279

1.47

1.58

1.1

29.64

5.53

nmol/l

0.41

Ulcerative colitis

567

1.32

1.58

1.1

1.70

8.59

nmol/l

—

113

Contraceptive management

130

735

1.24

1.58

1.1

0.68

3.83

nmol/l

1.67

131

Heart failure and antihypertensive medication

317

1.36

1.58

1.1

7.93

3.37

nmol/l

0.32

Zoster [herpes zoster]

396

1.39

1.57

1.1

0.91

9.96

nmol/l

—

Nontoxic multinodular goitre

396

1.39

1.57

1.0

1.1

2.22

9.19

nmol/l

0.92

Disorders of optic nerve and visual pathways

215

1.54

1.56

1.1

1.74

5.60

nmol/l

—

Melanocytic naevi of trunk

280

1.47

1.56

1.1

0.59

8.74

nmol/l

—

172

1296

1.20

1.56

1.1

2.01

6.30

nmol/l

1.78

260

Cutaneous abscess, furuncle and carbuncle

586

1.32

1.55

1.1

0.58

8.81

nmol/l

2.11

119

Fracture of lumbar spine and pelvis

439

1.37

1.55

1.1

1.14

10.64

nmol/l

1.95

100

Malignant melanoma, including Hilmo

364

1.40

1.54

1.1

1.0

3.88

7.15

nmol/l

0.77

Open wound of forearm

200

1.55

1.53

1.0

1.1

0.78

6.71

nmol/l

—

Mental and behavioural disorders due to alcohol

152

1207

1.21

1.53

1.1

0.63

6.31

nmol/l

3.41

242

Disorders of other and unspecified cranial nerves

3.39

1.53

1.0

1.1

—

Malignant neoplasm of tongue

0.00

1.52

0.0

1.1

—

1.67

—

Supervision of high-risk pregnancy

283

1.36

1.51

1.1

2.84

4.41

nmol/l

—

109

798

1.25

1.50

1.1

19.88

5.77

nmol/l

0.53

162

Primary gonarthrosis, bilateral

146

1030

1.21

1.50

1.1

8.05

6.14

nmol/l

0.19

209

Major coronary heart disease event excluding revascularizations

173

962

1.20

1.50

1.1

5.02

6.24

nmol/l

0.17

193

Ectopic pregnancy

434

1.36

1.50

1.1

1.17

12.13

nmol/l

1.40

Other viral diseases, not elsewhere classified

416

1.37

1.49

1.1

0.57

6.65

nmol/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

400

1.38

1.49

1.1

7.26

10.94

nmol/l

—

Complications predominantly related to the puerperium

661

1.29

1.48

1.1

0.22

6.39

nmol/l

1.46

127

Sudden idiopathic hearing loss

210

1.53

1.48

1.0

1.1

1.79

16.25

nmol/l

—

Systemic sclerosis (FG)

2.24

1.46

1.2

1.1

—

0.68

—

Congenital malformations of the respiratory system

2.24

1.46

1.0

1.1

—

0.11

—

Other superficial mycoses

235

1.49

1.46

1.1

2.60

5.15

nmol/l

—

Other diseases of stomach and duodenum

132

1.67

1.46

1.0

1.1

10.19

3.63

nmol/l

—

Unspecified privation

236

1.49

1.44

1.1

3.32

7.68

nmol/l

—

Glaucoma suspect

101

806

1.25

1.44

1.1

13.44

7.44

nmol/l

0.29

172

Other and/or unspecified nontoxic goitre

164

1.59

1.43

1.1

3.56

14.74

nmol/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

191

1283

1.18

1.43

1.0

1.1

0.36

6.32

nmol/l

3.52

253

Inguinal hernia

174

977

1.19

1.43

1.1

5.46

7.08

nmol/l

0.25

193

Papulosquamous disorders

117

951

1.23

1.42

1.1

9.10

6.58

nmol/l

0.22

196

Gastroduodenal ulcer

515

1.32

1.42

1.1

4.20

6.72

nmol/l

0.22

113

Hypertrophy of breast in women and men

482

1.33

1.41

1.1

0.75

8.44

nmol/l

1.21

Nasal polyp

388

1.37

1.40

1.1

2.95

11.07

nmol/l

1.13

Superficial injury of ankle and foot

262

1.45

1.40

1.0

1.1

2.17

5.45

nmol/l

—

Pneumocystosis

2.27

1.40

1.0

1.2

—

2.66

—

Congenital malformations of the respiratory system

2.27

1.40

1.0

1.1

—

0.09

—

Other disorders of breast

304

1.42

1.40

1.1

0.11

12.69

nmol/l

—

Glaucoma, exfoliation

189

1.54

1.39

1.0

1.1

1.64

12.96

nmol/l

—

Substance use, excluding alcohol

458

1.33

1.38

1.0

1.1

0.63

6.03

nmol/l

2.39

Acute suppurative otitis media

590

1.28

1.38

1.1

0.39

3.91

nmol/l

1.75

113

Outcome of delivery

233

1.38

1.37

1.1

0.18

5.27

nmol/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

162

1028

1.19

1.37

1.0

1.1

0.38

5.79

nmol/l

1.98

191

Nontoxic goitre/thyroid nodule

696

1.27

1.36

1.1

1.96

8.11

nmol/l

1.56

142

Non-allergic asthma

166

1.57

1.36

1.1

0.59

3.88

nmol/l

—

Malignant neoplasm of other and unspecified female genital organs

0.00

1.35

0.0

1.1

—

1.04

—

Scabies

315

1.40

1.34

1.1

0.61

5.33

nmol/l

—

Combinations of oral blood glucose lowering drugs

663

0.74

1.33

1.1

3.26

7.55

nmol/l

—

143

Heart failure and hypertrophic cardiomyopathy

0.00

1.33

0.0

1.2

—

0.14

—

Urolithiasis

726

1.25

1.32

1.1

3.36

8.01

nmol/l

0.96

147

Contact with machinery

208

1.49

1.32

1.0

1.1

1.05

6.44

nmol/l

—

Poisoning by medicine, drug-induced

0.00

1.31

0.0

1.1

—

0.08

—

Stenosis and insufficiency of lacrimal passages

160

1.57

1.31

1.3

1.1

1.95

12.19

nmol/l

—

Malignant neoplasm of anus and anal canal, including Hilmo

2.52

1.30

1.0

1.1

—

3.91

—

Sequelae of other external causes

121

1.66

1.30

1.2

1.1

5.03

3.35

nmol/l

—

Diabetic maculopathy, excluding more controls

217

1.48

1.30

1.0

1.1

0.10

6.27

nmol/l

—

Postmenopausal atrophic vaginitis

305

1.30

1.1

0.38

4.28

nmol/l

1.33

Iron deficiency anaemia secondary to blood loss (chronic)

343

1.37

1.29

1.1

0.09

10.43

nmol/l

—

Open wound of lower leg

318

1.39

1.28

1.1

6.89

13.04

nmol/l

—

Hypertrophy of breast

421

1.33

1.28

1.1

0.19

9.28

nmol/l

—

Other bullous disorders

1.95

1.28

1.0

1.1

—

1.85

—

Malignant melanoma of skin, including Hilmo

311

1.39

1.25

1.2

1.0

3.20

8.00

nmol/l

—

Struck by thrown, projected or falling objec

115

1.66

1.24

1.2

1.1

2.60

2.72

nmol/l

—

Morphin

2.23

1.24

1.0

1.1

—

7.71

—

Car occupant injured in other and unspecified transport accidents

432

1.32

1.24

1.1

0.72

5.40

nmol/l

2.00

Benign leiomyoma with endometriosis

363

1.35

1.24

1.1

14.50

9.33

nmol/l

0.24

Hypertrophic disorders of skin

131

1.61

1.23

1.0

1.1

4.15

6.91

nmol/l

—

Polyp of the female genital tract

392

1.26

1.23

1.1

4.05

3.38

nmol/l

0.06

Disorders of eyelid in diseases classified elsewhere

1.97

1.22

1.4

1.1

—

1.41

—

Agoraphobia

1.97

1.22

1.0

1.1

—

6.82

—

Injury of muscle and tendon at lower leg level

330

1.37

1.22

1.1

4.85

6.44

nmol/l

0.17

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

397

0.68

1.21

1.1

0.22

7.03

nmol/l

—

Occupational exposure to risk-factors

1.80

1.21

1.0

1.1

—

5.42

nmol/l

—

Anomalies of dental arch relationship, including avohilmo

422

1.30

1.21

1.2

1.1

2.16

4.94

nmol/l

0.70

Pregnancy hypertension

132

991

1.19

1.20

1.1

4.90

5.35

nmol/l

0.03

183

Diabetic maculopathy

208

1.45

1.20

1.0

1.1

0.10

3.81

nmol/l

—

Scleritis

2.12

1.19

1.1

—

0.33

—

Foreign body in respiratory tract

109

1.66

1.18

1.1

1.92

3.69

nmol/l

—

Other respiratory diseases principally affecting the interstitium

359

0.67

1.18

1.0

1.1

4.26

11.83

nmol/l

—

Pacemaker

629

1.25

1.18

1.1

8.48

8.55

nmol/l

0.00

130

Acute pancreatitis

401

1.32

1.18

1.1

8.26

10.61

nmol/l

0.14

severe traumatic brain injury, does not include concussion

437

1.31

1.16

1.1

6.85

6.47

nmol/l

0.02

Discitis, unspecified

0.00

1.16

0.0

1.1

—

10.44

—

Later onset COPD, excluding more controls

256

1.36

1.15

1.0

1.1

1.60

15.36

nmol/l

—

Schizophrenia, schizotypal and delusional disorders

749

1.23

1.15

1.1

1.61

7.06

nmol/l

1.39

148

Peripheral arterial reconstruction

248

0.60

1.15

1.0

3.33

0.11

nmol/l

—

Ulcerative colitis, NAS

317

1.36

1.14

1.1

2.10

6.82

nmol/l

—

Other/unspecified enthesopathies, not elsewhere classified

150

1.54

1.14

1.0

1.1

1.64

14.25

nmol/l

—

Abnormal findings on antenatal screening of mother

191

1.47

1.13

1.2

1.1

0.14

1.90

nmol/l

—

Diseases of external ear

796

1.22

1.13

1.1

4.66

7.24

nmol/l

0.29

166

Congenital malformations of the nervous system

1.91

1.12

1.1

—

0.48

—

Volvulus

1.91

1.12

1.3

1.2

—

5.26

—

Ventral hernia

528

1.27

1.12

1.1

0.47

9.70

nmol/l

2.08

105

Skin changes due to chronic exposure to nonionizing radiation

743

1.22

1.11

1.1

22.57

6.03

nmol/l

0.56

152

Fracture of neck

127

1.58

1.11

1.0

1.1

6.24

7.03

nmol/l

—

Otitis externa

502

1.28

1.11

1.1

6.22

8.67

nmol/l

0.16

102

Early lumbar disc prolapse operation

259

1.39

1.11

1.1

0.10

4.11

nmol/l

—

Other (seronegative) rheumatoid arthritis, wide

423

1.30

1.11

1.1

1.49

10.33

nmol/l

—

Corneal ulcer

415

1.30

1.10

1.1

3.08

9.62

nmol/l

0.79

Schizophrenia or delusion

746

1.22

1.08

1.1

1.61

7.10

nmol/l

1.40

147

Lichen planus

286

1.37

1.08

1.1

1.29

11.26

nmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

305

1751

1.12

1.08

1.1

8.58

4.57

nmol/l

0.30

338

Systemic sclerosis

1.93

1.06

1.2

—

1.17

—

Thoracic aortic aneurysm

287

1.36

1.06

1.1

4.24

8.17

nmol/l

—

Otitis media, unspecified

209

1.41

1.06

1.1

11.18

3.34

nmol/l

—

Other fall from one level to another

479

1.27

1.06

1.1

2.90

6.61

nmol/l

0.60

105

Burns and corrosions

296

1.35

1.05

1.2

1.1

0.15

5.67

nmol/l

—

Female infertility

413

1.24

1.05

1.0

1.1

0.30

4.26

nmol/l

1.45

Diabetes mellitus

338

1784

1.11

1.04

1.1

2.61

5.33

nmol/l

1.14

352

Hyperkalaemia

1.67

1.04

1.2

1.1

14.57

7.01

nmol/l

—

Colorectal adenocarcinoma

382

0.70

1.03

1.1

0.64

7.05

nmol/l

—

Disorders of continuity of bone

212

1.42

1.03

1.1

1.71

4.91

nmol/l

—

Salpingitis and oophoritis

428

1.29

1.03

1.0

1.1

0.77

9.61

nmol/l

—

Congenital malformations of heart and great arteries

263

1.37

1.03

1.1

5.09

5.72

nmol/l

—

Leiomyoma of uterus

196

972

1.14

1.02

1.1

2.43

5.92

nmol/l

0.65

172

Other infectious diseases

163

1.48

1.01

1.1

4.52

3.91

nmol/l

—

Dementia

107

616

1.20

1.00

1.0

1.1

4.15

9.46

nmol/l

0.87

132

Abnormal spermatozoa

226

0.62

1.00

1.1

—

8.37

—

Sequelae of injuries of lower limb

197

1.42

0.99

1.1

1.03

3.41

nmol/l

—

Idiopathic gout

172

1.46

0.99

1.0

1.1

5.71

7.82

nmol/l

0.27

Insulin, intermediate and long-acting

155

1306

1.15

0.99

1.1

4.74

5.91

nmol/l

0.15

262

Diseases of spleen

1.85

0.99

1.1

—

1.66

—

Pneumoconiosis due to asbestos and other mineral fibres

2.18

0.98

1.4

1.2

—

8.82

—

Acquired stenosis of external ear canal

0.00

0.98

0.0

1.2

—

2.25

—

Follicular adenocarcinoma of thyroid gland, including Hilmo

0.00

0.98

0.0

1.1

—

3.27

—

Malignant neoplasm of other and unspecified parts of biliary tract

0.00

0.98

0.0

1.1

—

2.08

—

Malignant neoplasm of other and unspecified parts of tongue

0.00

0.97

0.0

1.1

—

2.21

—

Palmar fascial fibromatosis [Dupuytren]

266

1.36

0.97

1.1

0.88

12.85

nmol/l

—

Suppurative and unspecified otitis media

107

799

1.19

0.97

1.1

3.98

6.11

nmol/l

0.20

155

Actinic keratosis

717

1.20

0.96

1.1

22.57

5.69

nmol/l

0.57

146

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

0.00

0.96

0.0

1.0

—

4.62

—

Other acquired deformities of musculoskeletal system and connective tissue

108

1.58

0.96

1.2

1.1

3.60

2.93

nmol/l

—

Deep bite

218

1.37

0.96

1.2

1.1

1.65

1.85

nmol/l

—

Sulfasalazine

612

1.23

0.96

1.1

5.50

6.69

nmol/l

0.07

100

Pyogenic arthritis

108

1.58

0.96

1.2

1.1

5.03

15.99

nmol/l

—

Rosacea

267

1.35

0.95

1.1

3.42

6.71

nmol/l

—

Hypertensive Heart Disease

359

1.27

0.95

1.1

8.44

8.87

nmol/l

—

Dementia, including avohilmo

115

670

1.18

0.95

1.0

1.1

3.94

9.11

nmol/l

0.94

147

Peritonsillar abscess

443

1.27

0.94

1.1

3.97

5.28

nmol/l

0.15

Medicines for HER+ breast cancer

874

0.82

0.94

1.1

1.20

6.60

nmol/l

1.57

167

Vascular dementia (mixed)

2.23

0.93

1.0

1.2

—

5.65

—

Primary coxarthrosis, bilateral

597

1.22

0.93

1.0

1.1

2.96

8.06

nmol/l

1.03

129

Diabetes mellitus in pregnancy

102

549

1.19

0.92

1.2

1.1

10.67

2.76

nmol/l

0.59

Disorder of lipoprotein metabolism, unspecified

243

1.36

0.92

1.1

5.10

13.44

nmol/l

—

FESS (DNB20)

295

1.32

0.92

1.1

2.62

7.93

nmol/l

1.08

Dermatophytosis

269

1.34

0.92

1.2

1.1

13.58

6.94

nmol/l

—

Type 1 diabetes

606

1.22

0.92

1.1

4.81

7.91

nmol/l

0.26

131

Colorectal cancer

465

0.76

0.91

1.2

1.1

2.79

6.59

nmol/l

0.74

103

Alzheimer disease, including avohilmo

525

0.80

0.91

1.0

1.1

1.38

9.98

nmol/l

2.09

120

Pregnancy, childbirth and the puerperium

371

1.21

0.91

1.1

8.69

5.00

nmol/l

0.23

Hyperfunction of pituitary gland

118

1.53

0.91

1.0

1.1

3.12

4.93

nmol/l

—

Other disorders of white blood cells

118

1.53

0.91

1.1

0.36

3.80

nmol/l

—

Disorders of tooth development and eruption

274

1.30

0.90

1.1

2.32

9.79

nmol/l

—

Adjustment and management of implanted device

340

1.30

0.90

1.0

1.1

3.49

6.91

nmol/l

0.69

Endometriosis diagnosis and infertility diagnosis occurring together

262

1.34

0.89

1.1

0.08

3.81

nmol/l

—

Other blood glucose lowering drugs, excl. Insulins

323

1.30

0.89

1.1

0.58

11.29

nmol/l

—

Benign lipomatous neoplasm

710

1.20

0.88

1.1

3.04

8.03

nmol/l

0.83

142

Leisure time condition

394

1.27

0.88

1.1

2.85

10.06

nmol/l

—

Calculus of kidney and ureter

674

1.20

0.88

1.1

3.02

8.26

nmol/l

1.06

140

Alcohol use disorder, Swedish definition

156

1254

1.14

0.88

1.1

2.09

6.10

nmol/l

1.52

250

Nontoxic single thyroid nodule

152

1.45

0.88

1.1

0.16

18.40

nmol/l

—

Any dementia, excluding more controls

468

1.21

0.88

1.0

1.1

1.93

9.94

nmol/l

1.54

101

Other disorders of pigmentation

1.58

0.87

1.0

1.2

0.11

8.23

nmol/l

—

Other/unspecified reactive arthropathies

144

1.46

0.87

1.1

0.17

4.53

nmol/l

—

Acute appendicitis, no complications

173

1523

1.13

0.87

1.1

1.08

5.92

nmol/l

2.79

288

IBD patients in KELA-register

539

1.23

0.86

1.1

1.44

8.17

nmol/l

1.26

107

Dermatitis herpetiformis

1.83

0.86

1.0

1.1

—

0.11

—

Other and unspecified nonorganic psychotic disorders

459

1.24

0.85

1.1

0.97

4.74

nmol/l

1.49

Heart failure and bmi 25plus

498

1.19

0.85

1.1

10.97

5.51

nmol/l

0.48

110

Malignant neoplasm of prostate, including Hilmo

394

0.80

0.85

1.0

1.1

5.42

6.96

nmol/l

0.23

Infections of breast associated with childbirth

1.63

0.84

1.4

1.1

0.40

8.51

nmol/l

—

Acute pancreatitis (for exclusion)

424

1.25

0.84

1.1

8.26

9.77

nmol/l

0.09

L02BA Anti-estrogens

400

0.75

0.83

1.1

1.08

8.52

nmol/l

—

Other diseases of intestine

283

1.31

0.83

1.1

3.49

6.03

nmol/l

—

Other coagulation defects

171

1.41

0.83

1.0

1.1

0.24

7.50

nmol/l

—

Other contact dermatitis

171

1.41

0.83

1.3

1.1

0.18

6.50

nmol/l

—

Non-ischemic cardiomyopathy

547

0.81

0.82

1.1

2.82

7.71

nmol/l

0.87

121

Hypertensive heart and/or renal disease

390

1.23

0.82

1.0

1.1

9.75

8.44

nmol/l

—

Pre-eclampsia or eclampsia

534

1.22

0.82

1.1

0.19

6.79

nmol/l

1.14

Gestational [pregnancy-induced] hypertension

679

1.19

0.81

1.1

11.68

5.29

nmol/l

—

122

Injuries involving multiple body regions

1.58

0.81

1.0

1.1

1.96

1.29

nmol/l

—

Injury of muscle and tendon at hip and thigh level

206

1.36

0.81

1.1

0.74

3.35

nmol/l

—

Fracture of femur

468

1.22

0.81

1.1

3.25

9.20

nmol/l

0.93

111

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

215

1.35

0.80

1.1

0.08

6.28

nmol/l

—

Insulin, fast-acting

101

866

1.17

0.80

1.1

5.91

7.46

nmol/l

0.16

173

Ulcer of lower limb, not elsewhere classified

285

1.30

0.79

1.1

0.10

12.12

nmol/l

—

Ethmoidectomy

303

1.29

0.79

1.1

2.62

7.78

nmol/l

1.06

Early onset COPD

482

1.23

0.79

1.0

1.1

8.63

8.74

nmol/l

0.01

111

Loose body in joint

1.82

0.79

1.0

—

4.41

—

Female infertility, cervical, vaginal, other or unspecified origin

406

1.20

0.79

1.1

0.28

4.26

nmol/l

1.38

Erythema intertrigo

1.67

0.79

1.0

1.1

—

4.75

—

Acquired absence of limb

0.00

0.78

0.0

1.0

—

2.67

—

Gout due to impairment of renal function

0.00

0.78

0.0

1.2

—

2.67

—

Later onset COPD

450

0.80

0.78

1.0

1.1

1.60

9.37

nmol/l

—

102

Cardiomyopathy, other and unspecified

156

1.41

0.78

1.0

1.1

0.09

8.19

nmol/l

—

Diabetes, varying definitions

332

1788

1.09

0.78

1.1

2.75

5.29

nmol/l

1.00

355

Other infective otitis externa

131

1.45

0.78

1.0

1.1

0.66

3.48

nmol/l

—

Viral warts

483

1.22

0.78

1.1

0.90

8.46

nmol/l

—

101

Fracture at wrist and hand level

793

1.17

0.78

1.0

1.1

2.08

7.81

nmol/l

1.62

156

Other congenital malformations of skin

182

1.38

0.77

1.2

1.1

0.09

6.63

nmol/l

—

Hydrocele

182

1.38

0.77

1.1

1.54

6.47

nmol/l

—

Diseases of appendix

230

1879

1.10

0.77

1.1

1.53

5.21

nmol/l

2.45

368

Infections with a predominantly sexual mode of transmission

118

957

1.15

0.77

1.1

1.11

5.30

nmol/l

1.26

177

Duodenal ulcer

210

0.67

0.76

1.0

1.1

12.16

4.20

nmol/l

—

Frostbite

0.00

0.76

0.0

1.1

—

0.08

—

Viral pneumonia

252

1.31

0.76

1.0

1.1

2.26

8.78

nmol/l

—

Systemic sclerosis, icd10

1.70

0.76

1.2

1.1

—

1.04

—

Type 2 diabetes

321

1724

1.09

0.75

1.0

1.1

2.74

5.20

nmol/l

0.94

338

Benign neoplasm: Ascending colon

279

1.29

0.75

1.1

1.10

12.75

nmol/l

—

Vitamin B12 deficiency anaemia

209

1.34

0.75

1.1

1.48

6.89

nmol/l

—

Malignant neoplasm, wide definition for exclusion

282

1512

1.09

0.75

1.1

9.48

4.51

nmol/l

0.39

285

Labour and delivery complicated by fetal stress [distress]

433

0.82

0.75

1.1

0.08

5.83

nmol/l

—

Rheumatoid arthritis, including avohilmo

106

919

1.15

0.75

1.1

5.17

6.70

nmol/l

0.16

192

Psoriasis vulgaris

432

1.23

0.74

1.1

11.71

9.96

nmol/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

514

1.21

0.73

1.1

1.31

9.66

nmol/l

—

102

Gout, FINNGEN

604

1.19

0.73

1.1

3.43

8.85

nmol/l

1.04

129

Crohn disease

298

1.28

0.73

1.0

1.1

12.99

7.16

nmol/l

—

Bronchiectasis

150

1.40

0.73

1.0

1.1

0.72

6.26

nmol/l

—

Abnormal results of function studies

193

1.35

0.73

1.1

13.89

6.49

nmol/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

350

1.25

0.72

1.1

5.65

6.94

nmol/l

—

Insulin medication

170

1281

1.12

0.72

1.1

4.39

5.88

nmol/l

0.23

260

Other and unspecified abdominal hernia

1.55

0.72

1.0

1.2

—

3.84

—

Insulin, fast-acting or short human

102

885

1.15

0.71

1.1

5.91

7.40

nmol/l

0.15

174

1.76

0.71

1.0

1.1

—

0.48

—

Other infectious diseases

194

1.34

0.71

1.1

4.52

4.58

nmol/l

—

Insulin, combination of fast acting with intermediate-acting or long-acting

170

1394

1.11

0.71

1.1

4.39

5.98

nmol/l

0.25

279

Lichen planus, including avohilmo

426

1.22

0.70

1.1

1.47

9.63

nmol/l

—

Foreign body on external eye

309

1.26

0.70

1.1

0.84

6.01

nmol/l

—

Fracture of forearm

156

1277

1.12

0.70

1.1

13.96

5.32

nmol/l

0.33

247

DVT of lower extremities

408

1.23

0.70

1.1

6.41

6.86

nmol/l

—

Other interstitial pulmonary diseases

309

0.74

0.70

1.0

1.1

4.26

12.38

nmol/l

—

Chronic periodontitis, complicated

153

1355

1.12

0.69

1.1

3.68

6.50

nmol/l

0.75

272

Interstitial lung disease endpoints

308

0.75

0.68

1.0

1.1

4.26

12.38

nmol/l

—

Interstitial lung disease

308

0.75

0.68

1.0

1.1

4.26

12.38

nmol/l

—

Alcohol abuse, main dg

337

1.25

0.68

1.1

1.17

6.66

nmol/l

—

Schizoaffective disorder

178

1.35

0.68

1.1

0.57

4.42

nmol/l

—

Pericarditis

1.60

0.68

1.0

1.1

7.91

9.04

nmol/l

—

malignant neoplasm of male genital organs

398

0.83

0.68

1.1

5.82

6.92

nmol/l

0.15

Benign neoplasm: Transverse colon

222

1.31

0.68

1.1

3.93

13.49

nmol/l

—

Invasive ventilation

144

1.39

0.68

1.1

1.35

4.66

nmol/l

—

Appendicitis, broad definition

226

1867

1.10

0.67

1.1

1.53

5.23

nmol/l

2.46

366

Other septicaemia

793

1.15

0.67

1.1

5.72

8.71

nmol/l

0.53

163

L02BG Aromatase inhibitors

713

0.84

0.67

1.1

1.43

6.37

nmol/l

—

137

Inflammatory bowel disease, strict (require KELA)

557

1.19

0.67

1.1

1.44

8.10

nmol/l

1.25

108

Injury of muscle and tendon at shoulder and upper arm level

826

1.15

0.67

1.1

4.15

7.18

nmol/l

0.46

171

Primary angle-closure glaucoma

0.54

0.67

1.0

1.1

—

9.34

—

Recurrent dislocation of patella

1.49

0.66

1.0

1.1

—

5.50

—

Malignant neoplasm of oral cavity, including Hilmo

0.53

0.66

1.0

1.1

—

11.06

nmol/l

—

Hypoglycaemia, other or unspecified

136

1.40

0.66

1.2

1.1

0.11

5.65

nmol/l

—

Alzheimer disease

444

0.82

0.66

1.0

1.1

1.90

11.39

nmol/l

—

103

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

312

1.25

0.66

1.2

1.1

1.32

12.13

nmol/l

—

Prepatellar bursitis

1.54

0.65

1.4

1.1

9.18

6.88

nmol/l

—

ILD, hospital admissions

305

0.75

0.65

1.0

1.1

4.26

12.47

nmol/l

—

Septicaemia

107

879

1.14

0.65

1.1

5.46

8.00

nmol/l

0.47

178

Fall on and from stairs and steps

587

1.18

0.64

1.0

1.1

1.99

8.52

nmol/l

1.17

121

Pre-eclampsia or poor fetal growth

798

1.15

0.64

1.1

0.17

6.35

nmol/l

1.64

145

Maternal care for known or suspected malpresentation of fetus

331

1.20

0.64

1.0

1.1

0.09

2.76

nmol/l

—

Other disorders of cornea

198

1.32

0.64

1.1

3.73

3.31

nmol/l

—

Diabetes medication

332

1830

1.08

0.63

1.0

1.1

2.70

5.23

nmol/l

1.02

361

Coagulation defects, purpura and other haemorrhagic conditions

432

1.20

0.63

1.0

1.1

1.87

10.55

nmol/l

1.34

Acute appendicitis

210

1796

1.09

0.62

1.1

1.54

5.41

nmol/l

2.46

351

Malignant neoplasm of breast, HER-positive

637

0.86

0.62

1.1

1.43

5.29

nmol/l

—

117

Myocardial infarction, with ST-elevation

336

0.77

0.62

1.0

1.1

5.81

7.35

nmol/l

—

Seropositive rheumatoid arthritis, strict definition

347

0.78

0.62

1.2

1.1

0.42

11.34

nmol/l

—

Injury of muscle and tendon at wrist and hand level

288

1.25

0.62

1.2

1.1

1.72

7.91

nmol/l

1.62

Glucagon-like peptide-1 (GLP-1) analogues

720

1.15

0.62

1.1

2.79

7.48

nmol/l

1.00

148

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

720

1.15

0.62

1.1

2.80

7.48

nmol/l

1.00

148

Arteriovenous malformation of cerebral vessels

1.67

0.61

1.0

1.1

—

0.08

—

Adalimumab

217

1.29

0.61

1.1

0.09

3.25

nmol/l

—

COPD

109

787

1.13

0.61

1.0

1.1

5.84

6.72

nmol/l

0.08

166

Prurigo nodularis

1.57

0.60

1.1

—

4.08

—

Complications peculiar to reattachment and amputation

0.00

0.59

0.0

1.2

—

0.12

—

Other diseases of blood and blood-forming organs

148

1.35

0.59

1.1

10.09

4.68

nmol/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.59

0.0

1.2

—

0.08

—

LSIL lesion of the cervix uteri

281

1.25

0.59

1.0

1.1

0.46

3.46

nmol/l

—

Fracture of foot, except ankle

556

1.17

0.58

1.0

1.1

2.51

8.33

nmol/l

0.83

114

Acute alcohol intoxication

556

1.17

0.58

1.1

0.91

6.98

nmol/l

3.91

119

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.58

0.0

1.1

—

0.12

—

Acute alcohol intoxication, ICD10

427

1.20

0.58

1.1

0.93

6.26

nmol/l

—

Peptic ulcer

0.00

0.58

0.0

1.1

—

2.22

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.58

0.0

1.2

—

0.08

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

418

1.20

0.58

1.1

0.73

6.42

nmol/l

—

Heart failure,strict

135

855

1.11

0.58

1.1

8.63

6.47

nmol/l

0.22

177

Malignant neoplasm of breast, ER-positive, including Hilmo

642

0.86

0.58

1.1

1.0

1.43

5.24

nmol/l

—

118

Other disorders of glucose regulation and pancreatic internal secretion

175

1.32

0.58

1.1

0.11

5.68

nmol/l

—

Delivery, wide proxy

427

1.14

0.58

1.1

7.61

4.42

nmol/l

0.20

Postpartum haemorrhage due to retained placenta

282

1.24

0.58

1.1

0.22

4.83

nmol/l

—

Benign neoplasm: Other/unspecified site

1.72

0.58

1.0

1.1

—

2.63

—

Biguanides

299

1696

1.07

0.57

1.0

1.1

3.41

5.52

nmol/l

0.68

335

Other congenital malformations

193

1.30

0.57

1.1

2.08

2.75

nmol/l

—

Atrial septal defect

0.58

0.56

1.0

1.1

—

1.32

nmol/l

—

Abnormal blood-pressure reading, without diagnosis

1.51

0.56

1.0

1.2

—

1.40

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

372

1.20

0.56

1.1

5.65

6.82

nmol/l

—

Vitreous haemorrhage

203

1.28

0.55

1.1

0.09

6.99

nmol/l

—

Benign neoplasm: Caecum

221

1.27

0.55

1.1

2.03

14.59

nmol/l

1.07

Superficial injury of shoulder and upper arm

230

1.26

0.55

1.1

5.24

7.74

nmol/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

120

1072

1.11

0.55

1.1

0.65

6.78

nmol/l

3.12

211

Secondary uncertain malignant neoplasm

266

1.24

0.55

1.0

1.1

3.72

7.71

nmol/l

—

Superficial injuries involving multiple body regions

1.52

0.52

1.0

1.1

1.96

1.26

nmol/l

—

Other chronic obstructive pulmonary disease

103

757

1.12

0.52

1.0

1.1

5.84

6.90

nmol/l

0.09

159

Bacterial, viral and other infectious agents

205

1.27

0.52

1.1

0.94

5.67

nmol/l

—

Cholecystitis

277

1.23

0.52

1.1

0.14

12.04

nmol/l

—

Lesion of plantar nerve

117

1.37

0.52

1.0

1.1

—

16.60

nmol/l

—

Malignant neoplasm of breast, HER2-negative

726

0.89

0.51

1.1

2.15

4.91

nmol/l

0.80

132

Maternal care for known or suspected fetal abnormality and damage

333

1.19

0.51

1.1

0.10

2.71

nmol/l

1.14

Myocardial infarction, unclassifiable

359

0.82

0.50

1.0

1.1

7.59

11.01

nmol/l

—

Gout, idiopatic and unspecified

509

1.16

0.50

1.1

3.61

8.89

nmol/l

0.86

112

Other predominantly sexually transmitted diseases, not elsewhere classified

500

1.16

0.50

1.0

1.1

0.10

3.36

nmol/l

1.70

104

Use of donepezil

342

0.81

0.50

1.0

1.1

2.34

12.03

nmol/l

—

Psoriasis

669

1.14

0.49

1.1

13.75

8.21

nmol/l

0.34

134

484

1.15

0.49

1.1

5.19

10.39

nmol/l

0.57

110

Other abnormal findings of blood chemistry

101

1.39

0.49

1.0

1.1

—

2.76

nmol/l

—

Melanocytic naevi, other sites/unspecified

180

1.28

0.49

1.2

1.1

—

4.17

nmol/l

—

Impacted cerumen

198

1.26

0.49

1.0

1.1

1.22

8.32

nmol/l

—

Tubulo-interstitial nephritis, not specified as acute or chronic

136

1.33

0.49

1.1

8.14

2.92

nmol/l

—

Insulin, fast-acting (human)

307

1.21

0.49

1.0

1.1

0.10

5.95

nmol/l

—

Perineal laceration during delivery

362

0.83

0.48

1.1

0.12

4.54

nmol/l

—

Other congenital malformations of the digestive system

107

0.65

0.48

1.0

1.2

—

2.86

—

Seborrhoeic keratosis

483

1.16

0.48

1.1

3.23

9.77

nmol/l

—

101

COPD, hospital admissions 1, only main diagnosis

636

0.87

0.48

1.0

1.1

5.74

8.09

nmol/l

—

136

Myeloproliferative diseases

181

1.27

0.48

1.2

1.1

7.49

7.51

nmol/l

—

Sub-endpoint used in defining T1D endpoints

651

1.13

0.47

1.0

1.1

4.74

5.90

nmol/l

0.09

132

Chronic kidney disease

594

1.14

0.47

1.1

1.25

9.71

nmol/l

2.26

125

Cellulitis

475

1.16

0.47

1.1

0.78

10.46

nmol/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

294

1664

1.06

0.47

1.0

1.1

2.73

5.35

nmol/l

0.96

328

Iridocyclitis in diseases classified elsewhere

1.46

0.47

1.0

1.1

—

1.50

—

ILD, hospital admissions 1, main diag only

277

0.79

0.46

1.0

1.1

4.26

7.93

nmol/l

—

Open wound of ankle and foot

218

1.24

0.46

1.0

1.1

2.75

5.00

nmol/l

—

Acute appendicitis, with complications

440

0.84

0.46

1.1

3.37

10.75

nmol/l

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

1.43

0.45

1.0

1.1

0.83

3.82

nmol/l

—

Malignant neoplasm of prostate

373

0.87

0.45

1.1

5.82

7.22

nmol/l

0.19

Dermatitis due to ingested food

1.40

0.45

1.0

1.2

—

0.25

—

Any death

148

1152

0.92

0.45

1.0

1.1

13.66

5.42

nmol/l

0.38

231

Normotensive glaucoma

165

1.27

0.45

1.2

1.1

1.38

18.02

nmol/l

—

Varicose veins

172

1201

1.08

0.44

1.1

4.93

5.77

nmol/l

0.14

240

Embedded and impacted teeth

502

1.13

0.44

1.2

1.1

1.24

3.94

nmol/l

0.75

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

184

1.25

0.43

1.2

1.1

20.97

5.62

nmol/l

—

Postprocedural disorders of digestive system, not elsewhere classified

1.41

0.43

1.0

1.1

—

3.80

—

Malignant neoplasm of breast

102

734

0.91

0.42

1.1

1.99

4.87

nmol/l

0.88

133

Malignant neoplasm of breast, including Hilmo

104

742

0.91

0.42

1.1

1.85

4.87

nmol/l

0.97

133

Benign neoplasm of mouth and pharynx

239

1.21

0.42

1.0

1.1

0.19

7.64

nmol/l

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

104

742

0.91

0.42

1.1

1.85

4.87

nmol/l

0.97

133

Generalized epilepsy

0.65

0.42

1.2

1.1

—

1.38

—

Supervision of normal pregnancy

289

1.15

0.42

1.0

1.1

0.89

4.50

nmol/l

—

Other complications of labour and delivery, not elsewhere classified

270

1.19

0.42

1.1

3.17

5.78

nmol/l

—

Other (not insulin) diabetes medications

305

1711

1.06

0.41

1.0

1.1

3.14

5.24

nmol/l

0.69

340

Respiratory disorders in diseases classified elsewhere

1.52

0.41

1.2

1.1

—

3.31

—

Marginal zone B-cell lymphoma, including Hilmo

1.52

0.41

1.0

1.1

—

5.03

—

Other specified and unspecified disorders of choroid

0.00

0.41

0.0

1.1

—

Non-seminoma of testis, including Hilmo

0.00

0.41

0.0

1.1

—

2.63

—

Gestational diabetes (for exclusion)

112

710

1.10

0.41

1.1

8.14

2.29

nmol/l

0.57

123

Type 2 diabetes, definitions combined

298

1654

1.06

0.41

1.0

1.1

3.38

5.39

nmol/l

0.63

326

Male infertility

1.39

0.40

1.2

1.1

—

2.16

—

Other keratitis

250

1.20

0.40

1.0

1.1

2.74

5.52

nmol/l

—

Benign neoplasm: Parotid gland

168

1.25

0.40

1.0

1.1

0.27

7.14

nmol/l

—

Maternal care for known or suspected abnormality of pelvic organs

437

1.12

0.40

1.1

9.21

4.01

nmol/l

0.29

Retinal breaks without detachment

343

1.17

0.39

1.1

13.56

10.16

nmol/l

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

532

0.87

0.39

1.1

0.15

5.76

nmol/l

—

110

Other specified/unspecified hearing loss

169

1.24

0.38

1.1

8.74

10.11

nmol/l

—

Type 2 diabetes, strict (exclude DM1)

298

1659

1.05

0.38

1.0

1.1

3.38

5.35

nmol/l

0.62

328

COPD, hospital admission 2, with asthma infections

586

1.11

0.38

1.0

1.1

6.22

7.99

nmol/l

0.13

127

Assault

289

1.18

0.37

1.1

2.40

5.46

nmol/l

—

Melanoma in situ

1.33

0.37

1.0

1.2

3.86

9.00

nmol/l

—

Infectious mononucleosis

179

1.23

0.37

1.0

1.1

0.16

5.02

nmol/l

—

Pyogenic granuloma

1.35

0.37

1.0

1.2

—

0.12

—

Explicit Sepsis

105

899

1.09

0.36

1.1

5.46

7.72

nmol/l

0.41

179

Myocardial infarction

118

764

1.09

0.36

1.0

1.1

5.98

6.57

nmol/l

0.06

161

Benign neoplasm: Kidney

1.36

0.36

1.2

1.1

0.43

4.38

nmol/l

—

Pre-eclampsia

497

1.13

0.36

1.1

0.22

7.15

nmol/l

1.07

Maternal care related to the fetus and amniotic cavity and possible delivery problems

125

677

1.08

0.36

1.1

2.04

6.55

nmol/l

0.69

129

Type 1 diabetes, wide definition, subgroup 1

497

1.13

0.35

1.0

1.1

7.50

5.22

nmol/l

—

106

Assault by bodily force

171

1.23

0.35

1.2

1.1

0.13

3.18

nmol/l

—

Colon adenocarcinoma

223

0.81

0.35

1.2

1.1

0.80

9.33

nmol/l

—

Aortic aneurysm

451

1.13

0.35

1.1

3.29

7.22

nmol/l

0.86

101

Atherosclerosis, excluding cerebral and coronary sclerosis

697

0.91

0.35

1.1

2.20

8.23

nmol/l

1.59

155

Benign neoplasm of bone and articular cartilage

190

1.21

0.34

1.0

1.1

0.09

6.24

nmol/l

—

Short Achilles tendon (acquired)

1.37

0.34

1.0

1.1

—

2.04

—

Cardiodefibrillation

774

1.10

0.34

1.0

1.1

7.88

7.12

nmol/l

0.05

173

Redundant prepuce, phimosis and paraphimosis

373

1.14

0.34

1.0

1.1

1.20

4.53

nmol/l

—

Cardiomyopathy

358

1.15

0.34

1.0

1.1

1.95

11.04

nmol/l

—

Habitual aborter

1.34

0.33

1.0

1.1

—

9.91

—

Superficial injury of thorax

302

1.16

0.33

1.1

1.37

6.92

nmol/l

—

Gout, strict definition

349

1.15

0.33

1.1

3.97

7.41

nmol/l

0.75

Desensitization to allergens

118

1.27

0.33

1.0

1.1

—

6.72

—

Other sexually transmitted chlamydial diseases

199

0.80

0.33

1.2

1.1

2.06

4.63

nmol/l

—

Myelodysplastic syndrome, including Hilmo

1.31

0.33

1.0

1.1

—

5.22

—

LSIL lesion of the cervix uteri, vagina or vulva

359

1.14

0.33

1.0

1.1

0.35

4.27

nmol/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

559

1.11

0.33

1.0

1.1

6.13

9.07

nmol/l

—

127

Operations 2 for CAVS

559

1.11

0.33

1.0

1.1

6.13

9.07

nmol/l

—

127

Other embolism and thrombosis

275

1.16

0.32

1.0

1.1

0.52

7.79

nmol/l

—

Chronic pancreatitis

238

1.18

0.32

1.1

4.65

6.06

nmol/l

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

146

1.23

0.32

1.1

1.24

3.77

nmol/l

—

Golimumab

1.33

0.32

1.2

1.1

—

0.61

—

N06DA Anticholinesterases

523

1.10

0.32

1.0

1.1

5.44

9.82

nmol/l

—

119

Use of anticholinesterases

523

1.10

0.32

1.0

1.1

5.44

9.82

nmol/l

—

119

Maternal care for known or suspected disproportion

1.31

0.31

1.0

1.1

—

7.21

—

Diabetic retinopathy

419

1.10

0.31

1.1

1.0

0.15

4.94

nmol/l

—

Calcific aortic valvular stenosis

561

1.11

0.31

1.0

1.1

6.13

9.07

nmol/l

—

127

Calcific aortic valvular stenosis, operated

561

1.11

0.31

1.0

1.1

6.13

9.07

nmol/l

—

127

Coronary artery bypass grafting

378

0.89

0.31

1.0

1.1

0.11

9.85

nmol/l

—

Diabetes, insulin treatment (Kela reimbursement)

306

1768

1.05

0.31

1.0

1.1

2.97

5.40

nmol/l

0.89

345

Other and unspecified nail disorders

1.32

0.31

1.0

1.1

—

1.68

—

Status post-ami

402

0.89

0.30

1.0

1.1

0.12

9.74

nmol/l

—

Lung cancer and mesothelioma

270

0.86

0.30

1.1

2.38

14.17

nmol/l

—

Calcific aortic valvular stenosis, including rheumatic fever

562

1.10

0.30

1.0

1.1

6.13

9.00

nmol/l

—

128

Explicit bacterial Sepsis

184

1.20

0.30

1.1

5.65

9.98

nmol/l

—

Presence of cardiac and vascular implants and grafts

103

709

1.08

0.30

1.0

1.1

7.12

7.04

nmol/l

0.00

159

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.34

0.30

1.3

1.1

—

4.48

—

Benign neoplasm: Conjunctiva

1.31

0.30

1.0

1.1

—

1.47

—

Other benign neoplasms of skin

879

1.08

0.30

1.0

1.1

2.38

7.50

nmol/l

1.34

181

Basal cell carcinoma, including avohilmo

122

784

1.07

0.30

1.1

1.0

1.27

5.73

nmol/l

3.07

156

Mucosal proctocolitis

287

1.15

0.30

1.1

0.09

5.92

nmol/l

—

Prolonged pregnancy

321

0.87

0.29

1.1

0.70

2.71

nmol/l

—

350

1.13

0.29

1.0

1.1

11.15

11.91

nmol/l

—

HSIL lesion of the cervix uteri

472

0.89

0.29

1.0

1.1

0.08

2.43

nmol/l

—

Other endocrine disorders

102

0.75

0.29

1.1

1.2

—

1.87

nmol/l

—

malignant neoplasm of female genital organs

322

0.86

0.29

1.0

54.24

4.26

nmol/l

—

Preterm labour and delivery

659

1.09

0.29

1.1

3.88

7.77

nmol/l

0.37

110

Seropositive rheumatoid arthritis, wide

621

1.10

0.29

1.1

2.95

7.96

nmol/l

0.81

130

Suggestive for eosinophilic asthma

195

1.18

0.28

1.1

4.67

7.33

nmol/l

—

Personal history of other diseases and conditions

257

0.85

0.27

1.0

1.1

3.88

4.27

nmol/l

—

Ulcerative colitis (strict definition, require KELA)

394

1.12

0.27

1.1

0.81

5.95

nmol/l

—

Any event in cancer register

285

1610

1.04

0.27

1.1

10.62

4.35

nmol/l

0.49

307

Alzheimer’s disease, strict definition

378

0.89

0.27

1.0

1.1

0.23

12.18

nmol/l

—

Type 2 diabetes, definitions combined, including avohilmo

297

1661

1.04

0.26

1.1

3.36

5.34

nmol/l

0.63

329

Antenatal screening

301

1.10

0.26

1.0

1.1

0.09

4.40

nmol/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

484

1.09

0.26

1.0

1.1

10.89

9.19

nmol/l

—

103

Residual foreign body in soft tissue

1.28

0.26

1.0

1.1

—

4.91

—

Burn and corrosion of trunk

0.68

0.26

1.2

1.1

—

3.81

—

Alzheimer’s disease (Early onset)

0.68

0.26

1.0

1.1

—

5.97

—

Other chronic obstructive pulmonary disease, including avohilmo

133

1036

1.06

0.26

1.0

1.1

4.62

6.35

nmol/l

0.23

219

Childhood allergy (age < 16)

216

1.14

0.26

1.1

0.86

4.48

nmol/l

—

Tooth eruption problems

293

1.13

0.25

1.1

0.09

3.92

nmol/l

—

Streptococcal septicaemia

169

1.18

0.25

1.1

5.65

7.94

nmol/l

—

Benign mammary dysplasia

320

1.13

0.25

1.1

0.55

10.80

nmol/l

—

Degenerative diseases of the nervous system

516

1.08

0.25

1.0

1.1

1.30

10.45

nmol/l

2.17

115

Malignant neoplasm of rectum, including Hilmo

245

0.86

0.25

1.0

1.1

0.10

9.55

nmol/l

—

Type1 diabetes, definitions combined, early onset

137

0.80

0.25

1.0

1.1

—

5.44

—

Acute alcohol intoxication ICD-9

1.20

0.25

1.1

—

5.13

—

Enterocolitis due to Clostridium difficile

217

1.15

0.24

1.0

1.1

0.14

7.52

nmol/l

—

Any dementia

556

1.07

0.24

1.0

1.1

1.85

9.65

nmol/l

1.88

124

Postpartum hemorraghe, all women as controls

656

1.08

0.24

1.1

0.18

4.05

nmol/l

1.60

116

Benign neoplasm: salivary glands, exclude unknown (D119)

189

1.17

0.24

1.0

1.1

0.24

8.05

nmol/l

—

Malignant neoplasm of skin

133

862

1.06

0.24

1.1

1.23

5.86

nmol/l

3.79

170

Myocardial infarction, without ST-elevation

784

1.07

0.24

1.0

1.1

8.57

7.84

nmol/l

0.05

173

Alcohol use disorder, ICD-based

106

997

1.06

0.23

1.1

0.68

6.93

nmol/l

3.03

203

Other acute viral hepatitis

1.32

0.23

1.2

1.1

—

0.08

—

Respiratory conditions due to other external agents

1.28

0.23

1.0

1.1

—

1.20

—

Other follicular disorders

162

1.17

0.22

1.1

0.12

6.63

nmol/l

—

Other congenital malformations of the digestive system

0.76

0.22

1.0

1.2

—

2.90

—

Postzoster neuralgia

1.25

0.22

1.2

—

3.03

—

Type 1 diabetes, wide definition

524

1.09

0.22

1.0

1.1

7.50

5.58

nmol/l

—

110

Benign neoplasm: Descending colon

153

1.18

0.22

1.1

0.20

4.54

nmol/l

—

L02BX Other hormone antagonists and related agents

0.74

0.22

1.0

1.1

—

11.60

—

Wet age-related macular degeneration

295

1.12

0.22

1.2

1.1

0.94

13.12

nmol/l

—

Medical abortion

190

986

1.05

0.22

1.1

1.29

6.77

nmol/l

1.76

182

Benign neoplasm: Other and unspecified parts of small intestine

1.22

0.22

1.0

1.1

—

1.04

—

Monocytic leukaemia

0.00

0.21

0.0

1.2

—

Benign neoplasm: Floor of mouth

0.00

0.21

0.0

1.2

—

Use of glatiramer acetate

1.19

0.21

1.0

1.1

—

0.33

—

Perichondritis of external ear

1.19

0.21

1.2

1.1

—

2.66

—

Retinal detachments and breaks

807

1.07

0.21

1.1

5.50

7.02

nmol/l

0.13

178

Listeriosis

0.00

0.21

0.0

1.2

—

Pedal cyclist injured in transport accident

522

0.92

0.20

1.0

1.1

0.83

8.80

nmol/l

1.54

101

Heart failure and coronary heart disease

634

1.06

0.20

1.0

1.1

9.75

7.16

nmol/l

0.20

136

Tick-borne viral encephalitis

0.00

0.20

0.0

1.1

—

Tick-borne viral encephalitis

0.00

0.20

0.0

1.1

—

Colectomy operation

345

1.10

0.20

1.1

31.47

7.53

nmol/l

0.36

Scissor bite

1.24

0.20

1.3

1.2

—

0.20

—

Benign neoplasm: Lip

1.23

0.20

1.2

1.1

—

2.37

—

Diabetic nephropathy

278

0.89

0.20

1.0

1.1

1.12

4.96

nmol/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

432

1.09

0.20

1.0

1.1

0.10

2.82

nmol/l

1.66

Other and unspecified vascular occlusions

176

0.85

0.20

1.1

2.65

16.68

nmol/l

—

Carcinoma in situ of skin of upper limb, including shoulder

1.20

0.19

1.0

1.1

—

3.51

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

384

1.09

0.19

1.1

0.81

6.08

nmol/l

—

Other/unspecified seropositive rheumatoid arthritis

616

1.07

0.19

1.1

2.95

8.02

nmol/l

0.82

129

Benign neoplasm of major salivary glands

212

1.13

0.19

1.0

1.1

0.22

7.71

nmol/l

—

In situ neoplasms

899

1.06

0.19

1.1

5.14

7.16

nmol/l

0.24

181

Dipeptidyl peptidase 4 (DPP-4) inhibitors

142

1087

1.05

0.19

1.0

1.1

3.77

6.40

nmol/l

0.52

225

Conductive hearing loss, unspecified

184

1.14

0.19

1.0

1.1

7.33

5.56

nmol/l

—

Other abnormal products of conception

601

1.06

0.19

1.1

0.08

5.19

nmol/l

—

Alzheimer’s disease (Late onset)

341

0.91

0.18

1.0

1.1

0.23

11.47

nmol/l

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

321

0.90

0.18

1.0

1.1

5.11

7.94

nmol/l

—

Chronic mastoiditis

1.17

0.18

1.1

—

3.31

—

214

1.12

0.17

1.1

2.49

4.90

nmol/l

—

Benign neoplasm of ovary

403

0.92

0.17

1.0

1.1

15.07

7.85

nmol/l

0.30

Nephropathy related operations

247

0.89

0.17

1.1

1.14

8.91

nmol/l

—

Other ulcerative colitis

131

0.84

0.17

1.0

1.1

—

4.49

—

Fracture of lower leg, including ankle

145

1379

1.04

0.17

1.1

1.98

5.95

nmol/l

1.58

270

Benign neoplasm: Skin of other and unspecified parts of face

224

1.12

0.17

1.0

1.1

2.75

7.64

nmol/l

—

Chorioretinal inflammation

0.71

0.16

1.0

1.1

—

2.79

—

COPD related to multimorbidity

730

1.05

0.16

1.0

1.1

6.10

7.69

nmol/l

0.13

154

Benign neoplasm of breast

282

1.10

0.16

1.1

12.10

12.17

nmol/l

—

Oesophageal obstruction

1.18

0.16

1.3

1.1

—

4.70

—

Otitis externa, unspecified

263

1.10

0.16

1.1

9.61

6.19

nmol/l

—

Diabetic retinopathy, strict definition

283

1.09

0.16

1.0

0.10

4.94

nmol/l

—

Paralytic ileus

1.14

0.16

1.1

—

5.12

—

Delirium, not induced by alcohol and other psychoactive substances

215

1.11

0.16

1.0

1.1

0.09

7.74

nmol/l

—

Injury of eye and orbit

293

1.09

0.15

1.1

1.37

8.18

nmol/l

—

Alcohol dependence

594

1.06

0.15

1.1

0.69

6.79

nmol/l

4.33

121

All dysplastic lesions of the cervix uteri, vagina or vulva

768

1.05

0.15

1.0

1.1

0.26

6.64

nmol/l

1.60

138

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

614

1.06

0.15

1.1

2.95

8.02

nmol/l

0.82

129

Postpartum haemorrhage

574

1.06

0.15

1.1

0.18

4.82

nmol/l

1.61

Malignant neoplasm of colon

296

0.91

0.14

1.2

1.1

3.32

8.35

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of head

1.18

0.14

1.0

1.2

—

0.34

nmol/l

—

Congenital malformations of genital organs

216

1.10

0.14

1.1

0.10

4.99

nmol/l

—

Infections with a predominantly sexual mode of transmission

782

1.05

0.13

1.1

0.74

5.96

nmol/l

1.46

152

Postpartum hemorraghe, parous women as controls

583

1.05

0.13

1.1

0.18

2.67

nmol/l

1.16

Pregnancy with abortive outcome

195

988

1.03

0.13

1.1

0.62

6.76

nmol/l

2.19

183

Toxic effects of substances chiefly nonmedicinal as to source

253

0.91

0.13

1.1

0.13

4.62

nmol/l

—

Mental and behavioural disorders due to sedatives or hypnotics

151

1.13

0.13

1.0

1.1

0.16

4.29

nmol/l

—

Lymphoid leukaemia

108

0.83

0.13

1.1

—

4.44

—

Other benign neoplasms of uterus

109

0.82

0.13

1.0

1.1

—

5.64

—

Fibrosis and cirrhosis of liver

169

0.89

0.12

1.1

13.46

7.40

nmol/l

—

Scar conditions and fibrosis of skin

1.18

0.12

1.0

1.1

—

1.84

—

Thiazolidinediones

229

1.09

0.12

1.0

1.1

5.45

13.06

nmol/l

—

Medical treatment for female infertility

566

0.95

0.12

1.1

0.09

2.13

nmol/l

1.21

Basal cell carcinoma

112

748

1.04

0.12

1.1

1.04

5.88

nmol/l

3.73

151

Dialysis, with operation codes

251

0.92

0.12

1.1

1.14

7.73

nmol/l

—

Delivery

542

0.96

0.11

1.1

6.90

3.60

nmol/l

0.24

111

Other malignant neoplasms of skin (=non-melanoma skin cancer)

110

780

0.97

0.11

1.1

0.78

5.73

nmol/l

4.18

156

HSIL lesion of the cervix uteri, vagina or vulva

516

0.95

0.11

1.0

1.1

0.08

3.27

nmol/l

—

Unspecified kidney failure

192

1.09

0.10

1.0

1.1

3.80

9.92

nmol/l

—

Atrophic disorders of skin

348

1.06

0.10

1.0

1.1

12.29

10.83

nmol/l

—

Purpura and other haemorrhagic conditions

280

1.07

0.10

1.0

1.1

2.67

8.61

nmol/l

—

Premature rupture of membranes

389

1.05

0.10

1.0

1.1

0.48

4.17

nmol/l

—

Other and unspecified iridocyclitis

1.15

0.10

1.3

1.1

—

2.71

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

329

1.06

0.10

1.1

0.81

7.01

nmol/l

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

1.14

0.10

1.0

1.1

—

1.15

—

Solid cancers, helper endpoint

241

1451

0.98

0.10

1.1

10.78

4.76

nmol/l

0.42

269

Malignant neoplasm

252

1462

1.02

0.09

1.1

10.94

4.71

nmol/l

0.43

272

Benign neoplasm of urinary organs

106

1.13

0.09

1.2

1.1

0.43

3.67

nmol/l

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

1.09

0.09

1.0

1.1

—

0.30

—

D07AA Corticosteroids, weak (group I)

359

1.06

0.09

1.1

0.12

6.00

nmol/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

348

1.05

0.09

1.2

1.1

11.56

8.03

nmol/l

0.28

Single delivery by caesarean section

248

0.95

0.09

1.1

3.97

4.63

nmol/l

—

Biological medication for rheuma

409

1.05

0.09

1.2

1.1

7.71

4.88

nmol/l

—

Unspecified lump in breast

380

1.05

0.08

1.1

6.47

10.88

nmol/l

—

Idiopathic urticaria

1.07

0.08

1.2

1.1

—

0.25

—

Persistent delusional disorders

175

0.91

0.08

1.2

1.1

4.37

4.08

nmol/l

—

Single spontaneous delivery

540

0.97

0.08

1.1

7.31

3.60

nmol/l

0.26

111

Benign neoplasm: Skin of scalp and neck

0.82

0.08

1.0

1.1

—

1.71

—

Respiratory tuberculosis, not confirmed

0.84

0.07

1.0

1.2

—

4.50

—

Pedal cyclist injured in other and unspecified transport accidents

245

0.94

0.07

1.1

1.44

6.02

nmol/l

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

196

1.07

0.07

1.1

0.20

9.16

nmol/l

—

Complications following abortion and ectopic and molar pregnancy

1.07

0.07

1.0

1.1

—

7.79

—

Impacted teeth

393

1.04

0.07

1.2

1.1

1.82

4.59

nmol/l

—

Retinal vascular disorders

234

0.94

0.06

1.0

1.1

2.28

13.32

nmol/l

—

Degenerative macular diseases

236

1.06

0.06

1.1

0.10

12.44

nmol/l

—

Peripheral artery disease

754

1.02

0.06

1.1

1.69

7.98

nmol/l

2.00

166

Diabetic nephropathy, excluding more controls

217

0.95

0.06

1.0

1.12

4.28

nmol/l

—

Tumor necrosis factor alpha inhibitors

375

1.04

0.05

1.1

8.58

3.57

nmol/l

—

Obstructed labour due to malposition and malpresentation of fetus

556

0.97

0.05

1.1

0.16

5.09

nmol/l

—

Glomerular disorders in diseases classified elsewhere

232

0.95

0.05

1.0

1.1

0.11

8.59

nmol/l

—

Endovascular or surgical operations to intracerebral aneurysms

120

1.08

0.05

1.0

1.1

0.25

5.72

nmol/l

—

Malignant neoplasm of breast, HER-negative

435

0.97

0.04

1.1

1.0

3.94

5.21

nmol/l

—

Retinal vascular occlusion

231

0.95

0.04

1.0

1.1

2.28

13.34

nmol/l

—

COPD, hospital admissions

102

849

1.02

0.03

1.0

1.1

5.84

6.75

nmol/l

0.08

183

Emphysema

131

1.07

0.03

1.1

—

7.11

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

123

823

1.01

0.03

1.0

0.89

5.75

nmol/l

3.89

161

Complications of labour and delivery

178

980

1.01

0.03

1.1

2.04

6.56

nmol/l

0.95

176

Myocardial infarction, strict

101

709

1.01

0.03

1.0

1.1

6.22

6.93

nmol/l

0.07

149

All-cause Heart Failure

138

964

1.01

0.02

1.1

8.42

6.44

nmol/l

0.21

195

COPD, early/later onset

103

860

1.01

0.01

1.0

1.1

5.84

6.67

nmol/l

0.07

185

Heart failure, strict

138

980

0.99

0.01

1.1

8.42

6.36

nmol/l

0.22

201

Glomerulonephritis

207

0.97

0.01

1.2

1.1

2.64

5.47

nmol/l

—

Abnormalities of forces of labour

243

1.03

0.01

1.1

0.10

7.99

nmol/l

—

Pleural effusion

297

0.98

0.01

1.2

1.1

2.50

12.52

nmol/l

—

Malignant neoplasm of kidney, except renal pelvis

176

0.97

0.00

1.1

0.20

9.57

nmol/l

—

Lichen sclerosus et atrophicus

226

0.97

0.00

1.0

1.1

13.00

13.36

nmol/l

—

Spontaneous abortion

129

865

1.01

0.00

1.1

0.36

7.37

nmol/l

2.15

156

Unspecific neurodegenerative disorder

590

1.00

0.00

1.0

1.1

5.32

8.77

nmol/l

0.38

133

All dysplastic lesions of the cervix uteri

694

1.00

0.00

1.0

1.1

0.30

3.42

nmol/l

1.51

122

Arthropathic psoriasis

262

0.99

0.00

1.1

20.03

5.14

nmol/l

—

Gout, unspecified

415

0.99

0.00

1.1

1.43

6.71

nmol/l

—

Malignant neoplasm of breast, ER-negative, including Hilmo

484

1.00

0.00

1.1

1.0

2.84

5.56

nmol/l

—

Malignant neoplasm of colon, including Hilmo

379

1.00

0.00

1.2

1.1

2.74

7.36

nmol/l

1.04

Other disorders of kidney and ureter

273

0.99

0.00

1.1

0.87

7.30

nmol/l

—

Malignant neoplasm of urinary organs

189

1.01

0.00

1.1

0.20

9.53

nmol/l

—

Glomerular diseases

381

1.00

0.00

1.1

1.51

11.12

nmol/l

—

Follicular cysts of skin and subcutaneous tissue

409

1.00

0.00

1.0

1.1

0.14

10.50

nmol/l

—

Transplanted organ and tissue status

191

0.99

0.00

1.1

2.02

5.54

nmol/l

—

Rickettsioses

0.00

0.0

1.4

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.0

1.0

—

Polyp of middle ear

0.00

0.0

1.3

—

Abscess of mediastinum

0.00

0.0

1.0

—

Congenital malposition of the kidney

0.00

0.0

1.4

—

Hookworm diseases

0.00

0.0

1.0

—

Kaposi sarcoma, including Hilmo

0.00

0.0

1.0

—

Crushing injury of forearm

0.00

0.0

1.0

—

Other parasitologically confirmed or unspecified malaria

0.00

0.0

1.0

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.0

1.2

—

Other infective spondylopathies

0.00

0.0

1.3

—

Other and unspecified injuries of wrist and hand

1.01

0.00

1.2

1.1

—

1.38

—

Malignant neoplasm of accessory sinuses

0.00

0.0

1.0

—

Allergic bronchopulmonary aspergillosis (ABPA)

0.00

0.0

1.4

—

Thoracic root disorders

0.00

0.0

1.0

—

Scleritis and episcleritis in diseases classified elsewhere

0.00

-0.00

0.0

1.4

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.3

—

Disorders of sexual preference

0.00

-0.00

0.0

1.4

—

Hereditary lymphedema

0.00

-0.00

0.0

1.3

—

Other nonautoimmune haemolytic anaemias

0.00

-0.00

0.0

1.4

—

Hereditary lymphedema

0.00

-0.00

0.0

1.3

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

1.00

-0.00

1.1

—

4.15

—

Sunburn

0.00

-0.00

0.0

1.3

—

Chondrosarcoma

0.00

-0.00

0.0

1.0

—

Defect, injury or illness of lumbar spine

0.00

-0.00

0.0

1.0

—

Rapidly progressive nephritic syndrome

0.00

-0.00

0.0

1.4

—

Medullary cystic kidney disease, nephronophthisis

0.00

-0.00

0.0

1.4

—

Hereditary sideroblastic anaemia

0.00

-0.00

0.0

1.3

—

Blindness or visual impairment, binocular

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Female genital organ, unspecified

0.00

-0.00

0.0

1.0

—

Other congenital malformations of integument

0.00

-0.00

0.0

1.3

—

Benign neoplasm: Hypopharynx

0.00

-0.00

0.0

1.3

—

Benign neoplasm: Connective and other soft tissue of abdomen

0.00

-0.00

0.0

1.3

—

Postpolio syndrome

0.00

-0.00

0.0

1.4

—

Adenocarcinoma of small intestine

0.00

-0.00

0.0

1.0

—

Defect, injury or illness of face

0.00

-0.00

0.0

1.0

—

Hypotony of eye

0.00

-0.00

0.0

1.4

—

Fitting and adjustment of external prosthetic device

0.00

-0.00

0.0

1.3

—

Other and unspecified disorders of globe

0.00

-0.00

0.0

1.3

—

Need for immunization against single bacterial diseases

0.00

-0.00

0.0

1.0

—

Other retinal disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.4

—

Choroidal degeneration

0.00

-0.00

0.0

1.3

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of vagina

0.00

-0.00

0.0

1.0

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

0.00

-0.00

0.0

1.0

—

Ulcerative enterocolitis

0.96

-0.00

1.0

1.1

—

0.33

—

Other disorders involving the immune mechanism, not elsewhere classified

0.92

-0.00

1.1

—

4.15

—

Kyphoscoliotic heart disease

0.00

-0.00

0.0

1.0

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

-0.00

0.0

1.4

—

Lupus nephritis

0.00

-0.00

0.0

1.0

—

Traumatic spondylopathy

0.00

-0.00

0.0

1.0

—

Injury of blood vessels at shoulder and upper arm level

0.00

-0.00

0.0

1.3

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

-0.00

0.0

1.3

—

Endocrine disorders, other/unspecified

1.00

-0.00

1.0

1.1

—

1.20

nmol/l

—

Benign neoplasm: Liver/bile ducts (ICD-9)

0.00

-0.00

0.0

1.0

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

-0.00

0.0

1.4

—

Small kidney of unknown cause

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of gallbladder

0.00

-0.00

0.0

1.0

—

ILD medications: nintedanib

0.00

-0.00

0.0

1.4

—

Cutaneous autosensitization

0.00

-0.00

0.0

1.0

—

Chronic constrictive pericarditis

0.00

-0.00

0.0

1.4

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

-0.00

0.0

1.0

—

Other and unspecified vasculitis limited to skin

0.96

-0.00

1.0

1.2

—

2.38

—

Other sideroblastic anaemias

0.00

-0.00

0.0

1.2

—

Choroidal detachment

0.00

-0.00

0.0

1.4

—

Iodine-deficiency-related goitre

0.00

-0.00

0.0

1.3

—

Subclinical iodine-deficiency hypothyroidism

0.00

-0.00

0.0

1.3

—

Poikiloderma of Civatte

0.00

-0.00

0.0

1.3

—

Other helminthiases

0.00

-0.00

0.0

1.0

—

Contact with sharp object, undetermined intent

0.91

-0.00

1.4

1.1

—

1.83

—

Other disorders of Eustachian tube

1.00

-0.00

1.0

1.1

—

1.58

nmol/l

—

Hypoplasia of dental enamel, prenatal , including avohilmo

0.00

-0.00

0.0

1.3

—

Lichenoid drug reaction

0.00

-0.00

0.0

1.2

—

Yaws

0.00

-0.00

0.0

1.2

—

Frostbite with tissue necrosis

0.00

-0.00

0.0

1.3

—

Exposure to controlled fire, not in building or structure

0.00

-0.00

0.0

1.4

—

Radiodermatitis

0.00

-0.00

0.0

1.3

—

Other chromosome abnormalities, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Mumps

0.91

-0.00

1.0

1.1

—

1.08

—

Toxic effect of other noxious substances eaten as food

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

-0.00

0.0

1.0

—

Calcium deposit in bursa

0.00

-0.00

0.0

1.0

—

Secondary sideroblastic anaemia

0.00

-0.00

0.0

1.0

—

Drug-induced thyroiditis

0.00

-0.00

0.0

1.3

—

Rickettsioses

0.00

-0.00

0.0

1.4

—

Telogen effluvium

0.00

-0.00

0.0

1.0

—

Organic amnesic syndrome, not induced by alcohol and other psychoactive substances

0.00

-0.00

0.0

1.4

—

Vascular dementia (sudden onset)

0.00

-0.00

0.0

1.3

—

Flexion deformity

0.00

-0.00

0.0

1.0

—

Alkalosis

0.00

-0.00

0.0

1.3

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Acetylcholine receptor Ab [Moles/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS